Food Microbiology Testing Market Size, Share & Trends Analysis Report by Technology (Traditional Culture and Selective Media Culture), by Test Type (Pathogen, Genetically Modified Organism, Allergen, Chemicals and pesticides, and Others), by Food Tested (Meat, Poultry & Seafood, Dairy Products, Processed Foods, Fruits & Vegetables and Others) and by End-Users (Large-Scale Producers and Small and Medium Enterprises), Forecast Period (2025-2035)
Published: Feb 2026
Food microbiology testing market was valued at $16.4 billion in 2024 and is projected to reach $39.4 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2025-2035). The global food microbiology testing market is witnessing substantial growth due to rising issues over food safety and quality. Expanding cases of foodborne diseases have heightened the need for secure testing results. Regulatory bodies globally are enforcing stricter compliance ethics to ensure consumer protection. Advancements in quick testing technologies are streamlining discovery processes across the force chain. The growing demand for reused and packaged food is correspondingly contributing to the market expansion. Furthermore, the globalization of food trade necessitates robust microbiological testing protocols to maintain international safety norms.
DNA Methylation Detection Technology Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments, and Software), by Technology (Polymerase Chain Reaction (PCR), Microarray, and Sequencing), by Application (Translational Research, and Diagnostic Procedure), and by End-Users (Contract Research Organization (CRO), Research and Academic Laboratories, and Biopharmaceutical and Biotech Companies), Forecast Period (2025-2035)
Published: Feb 2026
DNA methylation detection technology market was valued at $1,675 million in 2024 and is anticipated to reach $7,253 million by 2035, growing at a CAGR of 14.3% during 2025–2035. The DNA methylation detection technologies market is driven by the increasing popularity of precision medicine and the growing emphasis on early detection of diseases. Rising awareness of the role of epigenetics in various diseases, especially cancer, is further accelerating demand. Innovations in next-generation sequencing (NGS) and microarray-based platforms are enhancing the accuracy of methylation pattern detection while providing other clinical advantages in both research and diagnostics. Additionally, the increase in research and development from public and private sectors also aims directly towards the expansion of clinical trials and biomarker discovery projects are fueling innovation and supporting steady market growth across several applications.
Thermal Cyclers Market Size, Share & Trends Analysis Report by Product Type (Instruments, Consumables, and Accessories), by Application (Diagnostics, Sequencing, Cloning, Genotyping, Mutagenesis, Manufacturing and Quality Control Testing, Clinical Research, and Others), by End-Users (Pharmaceutical Industries, Academic and Research Institutes and Diagnostic Laboratories) Forecast Period (2024-2031)
Published: Feb 2026
Thermal cyclers market is anticipated to grow at a significant CAGR of 10.9% during the forecast period (2024-2031). The market growth is attributed to the increasing progress in the field of genomics research. Thermal cyclers are critical to many industries, such as pharmaceuticals, forensic science, research labs, and medical diagnostics. Their ability to quickly and accurately amplify DNA makes them indispensable for tasks such as pathogen detection, gene expression analysis, and genetic issue detection.
Cell Processing Instrument Market Size, Share & Trends Analysis Report by Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Other Instruments), by Application (Cell Isolation/Separation, Cell Imaging & Counting, Cell Viability & Proliferation, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Cell processing instrument market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). Cell processing instrument is a specialized tool used to manipulate and prepare cells for various purposes, including cell-based therapies, regenerative medicine, and vaccine development. Its importance lies in utilizing healthy cells to fight diseases or repair damaged tissues.
Microscopy Market Size, Share & Trends Analysis Report by Technology (Optical Microscopes (Upright Microscopes, Inverted Microscopes, Stereomicroscopes, Fluorescence Microscopes, Confocal Scanning Microscopes, & Near Field Scanning Microscopes), and Electron Microscopes Transmission Microscopes, & Scanning Electron Microscopes)), and by Application (Life Science & Healthcare, Semiconductors & Electronics, and Others (Food & Beverage, Automotive)), Forecast Period (2024-2031)
Published: Feb 2026
Microscopy market is anticipated to grow at a CAGR of 5.3% during the forecast period (2024-2031). Microscopy is a field of technical science that studies, magnifies, and views objects that are too small to see with the naked eye. Microscopy can be further divided into optical and electron microscopy. It is defined as the science of analyzing the nature, qualities, and structure of an object using a device known as a microscope. The growth of the microscopy market is attributed to increasing applications and advancements in microscopes such as high- and super-resolution microscopes, automated and intelligent microscopes, integrated imaging systems, and multi-photon microscopy.
Bioprocess Monitoring Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Instruments and Software), by Application (Host Cell Residual DNA/Protein Quantitation, Mycoplasma Detection, Viral Titer Determination, and Adventitious Virus Testing), and by End-Use (Pharmaceutical & Biotechnology Companies, CROs & CMOs, and Academic & Research Institutes), Forecast Period (2024-2031)
Published: Feb 2026
Bioprocess monitoring market is anticipated to grow at a CAGR of 8.4% during the forecast period (2024-2031). Bioprocess monitoring refers to the systematic observation, measurement, and control of various parameters during a bioprocess to ensure optimal conditions for the production of biological products. The market growth is attributed in large part to the growing adoption of biopharmaceuticals and biotechnology processes. As a result, there is a growing need for more reliable and accurate bioprocess monitoring instruments.
Protein Chip Market Size, Share & Trends Analysis Report by Type (Analytical Microarrays, Functional Protein Microarrays, and Reverse Phase Protein Microarrays), by Application (Antibody Characterization, Clinical Diagnostics, and Proteomics), and by End-Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories and Hospitals & Clinics), Forecast Period (2024-2031)
Published: Feb 2026
Protein chip market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). Protein chip, also known as a protein microarray, is a high-throughput technology used in proteomics for the parallel detection and quantification of multiple proteins in a single experiment. It consists of a solid surface, typically a glass slide or a silicon chip, onto which specific capture molecules such as antibodies, peptides, or proteins are immobilized in an array format. Major factors supporting the protein microarray market growth are the increasing demand for personalized medicine and precision diagnostics, technological investments, and innovations.
Whole Genome Amplification Market Size, Share & Trends Analysis Report by Product Type (Instruments, Kits and Reagents, and Services), by Application (Drug Discovery and Development, Disease Diagnosis, Agriculture, Veterinary Research, Forensics, and Others), and by End-User (Pharma and Biotech Companies, Contract Research Organizations, Academic Institutes, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Whole genome amplification market is anticipated to grow at a CAGR of 7.3% during the forecast period (2024-2031). Whole genome amplification is the process of amplifying the entire genome from nanogram quantities of DNA to microgram quantities of amplified products. It has been used to amps up material from a single DNA cell and is an important tool for the preservation of small samples of DNA products. Numerous techniques, such as primer extension preamplification, multiple displacement amplification, and degenerate oligonucleotide PCR, have been developed for whole genome amplification.
Lung Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report by Biomarker (Circulating Nucleic Acids, CTC, Exosomes/Microvesicles, Circulating Proteins), by Application (Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring), by End-User(Hospitals and Laboratories, Specialty Clinics, Academic and Research Centers), by Product (Instruments, Consumables Kits and Reagents, Software and Services) Forecast Period (2024-2031)
Published: Feb 2026
Lung cancer liquid biopsy market is anticipated to grow at a significant CAGR of 13.4% during the forecast period (2024-2031). Lung cancer liquid biopsy is a diagnostic technique for lung cancer detection and monitoring, using biomarkers in bodily fluids. It's minimally invasive, real-time, and provides comprehensive tumor profiling. It aids in early detection, treatment response, disease progression assessment, and therapy resistance identification. This advancement in oncology improves patient outcomes.
Laboratory Filtration Market Size, Share & Trends Analysis Report by Product (Filters & Filter Media, Filtration Assemblies and Filtration Accessories), by Material (Filtration Membrane and Filtration Media), by Technology (Microfiltration, Nanofiltration, Vacuum Filtration, Ultrafiltration and Reverse Osmosis), by Type (Sterile Filtration and Non-Sterile Filtration), and by End-Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospital & Clinical Laboratories) Forecast Period (2024-2031)
Published: Feb 2026
laboratory filtration market is anticipated to grow at a moderate CAGR of 12.8% during the forecast period (2024-2031). The market growth is attributed to the rise in investment in R&D in the biotechnology and pharmaceutical industries, a growing trend in the adoption of membrane filtration, a growth in the demand for single-use filtration products, and stricter regulatory requirements. Furthermore, the market is growing owing to the rise in demand for advanced membrane filtration systems and the rising number of laboratories in developing nations. According to the International Laboratory Accreditation Cooperation (ILAC), in October 2022, 85,000 laboratories were operating globally.
Metagenomic Sequencing Market Size, Share & Trends Analysis Report by Application (Drug Discovery, Clinical Diagnostic, Soil Microbiome, Industrial Applications, Ecological and Environmental and Veterinary), by Product & Service (Reagents and Consumables, Instruments, Sequencing Services, and Analysis and Data Interpretation Solutions), by Technology (16s RNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, and Metatranscrigptomics), and by Workflow (Sample Preparation, Sequencing, and Data Processing and Analysis), Forecast Period (2025-2035)
Published: Feb 2026
Metagenomic Sequencing market was valued at $2.2 billion in 2024 and is projected to reach $13.7 billion by 2035, growing at a CAGR of 17.7% during the forecast period (2025-2035). The metagenomic sequencing sector is experiencing sustained growth, largely propelled by advancements in next-generation sequencing technologies that have significantly enhanced accuracy, processing speed, and cost-efficiency, facilitating broader and more rapid adoption across applications. The increasing emphasis on early disease detection and personalized medicine supports the accelerating acceptance of technology. There are more investments in microbiome research, both within healthcare and environmental research, that are stimulating market growth, government stimulus funding, and public/private partnerships promoting innovation in genomics.
Preimplantation Genetic Testing Market Size, Share & Trends Analysis Report by ProcedureType (Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis), by Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Comparative Genomic Hybridization and Single-Nucleotide Polymorphism), by Product (Reagents and Consumables, Instruments and Software and Services) by Application (Aneuploidy, Structural Chromosomal Abnormalities, Single Gene Disorders, X-Linked Disorders, HLA Typing and Gender Identification) and by End-User (Fertility Clinics, Hospitals and Diagnostic Laboratories) Forecast Period (2024-2031)
Published: Feb 2026
Preimplantation genetic testing market is anticipated to grow at a significant CAGR of 11.9% during the forecast period (2024-2031). Preimplantation genetic testing is a process used during in vitro fertilization (IVF) to screen embryos for genetic abnormalities before they are implanted into the uterus. This screening helps identify embryos that are free from certain genetic disorders or chromosomal abnormalities, allowing healthcare providers to select the healthiest embryos for implantation.
Biocomponent Fiber Market Size, Share & Trends Analysis Report by Material (PE/PP, PE/PET, Co-PET/PET and Polyester/PBT5), by Structure Types (Sheath-core, Side-by-Side, Islands in the Sea, and Other Structure Types), and by End-user Industry (Non-Woven Textiles, Automotive, Hygiene, Construction, Medical and Other End-user Industries) Forecast Period (2024-2031)
Published: Feb 2026
Biocomponent fiber market is anticipated to grow at a considerable CAGR of 6.6% during the forecast period (2024-2031). Bicomponent fiber is a specialized type of textile fiber composed of two different polymer components within a single filament. It offers unique properties and performance characteristics, making it highly versatile for various textile applications.
Microbial Identification Market Size, Share & Trends Analysis Report by Product & Service (Instrument, Consumables, Software & Services), by Technology (Mass Spectrometry, PCR, Microarrays, and Next Generation Sequencing) by Method (Phenotypic Methods, Genotypic Methods, and Proteotypic Methods), by Application (Clinical Diagnostics, Pharmaceuticals, Food & Beverage Testing, and Environmental Application) Forecast Period (2024-2031)
Published: Feb 2026
Microbial identification market is anticipated to grow at a significant CAGR of 10.5% during the forecast period (2024-2031). Microbial Identifications is a characterization of a certain microorganism through an appropriate test method able to return the name of the analyzed species.
Microbiome Diagnostic Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, and Instruments), by Technology (16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics, and Other), and by End-Users (Hospitals, Academic and Research Institutes and Biotechnology, and Pharmaceutical Companies) Forecast Period (2024-2031)
Published: Feb 2026
Microbiome diagnostic market is anticipated to grow at a CAGR of 11.4% during the forecast period (2024-2031). The growing adoption of advanced technologies such as 16S rRNA sequencing, shotgun metagenomics, and metatranscriptomics with increasing demand for the human microbiome are key factors supporting the growth of the market globally. The market players are introducing microbiome diagnostic solutions that further bolster the market growth.
Gene Expression Analysis Market Size, Share & Trends Analysis Report By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Microarray), by Product (Instruments, Reagents & Consumables, and Services), By End-User (Drug Discovery and Development, Diagnostic Laboratories, and Academic Research Centers) Forecast Period (2024-2031)
Published: Feb 2026
Gene expression analysis market is anticipated to grow at a considerable CAGR of 8.6% during the forecast period (2024-2031). The increasing advancements in genomic research, increasing prevalence of chronic disorders, and growing demand for gene expression analysis tools are major factors driving the global market.
Hollow Fiber Filtration Market Size, Share & Trends Analysis Report by Membrane Material (Polysulfone (PS), Mixed Cellulose Ester, Polyvinylidene Difluoride (PVDF) and Polyethersulfone (PES) by Process (Single-use Hollow Fiber Membranes and Reusable Hollow Fiber Membranes), and by Application (Virus or Viral Vector Filtration, Protein Concentration & Diafiltration, Cell Culture Harvest & Clarification and Others), Forecast Period (2023-2030)
Published: Feb 2026
Hollow fiber filtration market is anticipated to grow at a CAGR of 12.2% during the forecast period (2023-2030). The growing adoption of hollow fiber filters in diafiltration, ultrafiltration, and microfiltration procedures in biopharmaceutical manufacturing is the key factor supporting the growth of the market globally. The market players are also focusing on developing membrane filtration solutions for a variety of applications, including fuel cells that further bolster the market growth.
Laboratory Proficiency Testing Market Size, Share & Trends Analysis Report by Industry Type (Clinical Diagnostics, Microbiology, Pharmaceuticals, Biologics, and Others), and by Technology (Polymerase Chain Reaction, Immunoassays, Chromatography, Spectrometry, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Laboratory proficiency testing market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). The market’s growth is attributed to the demand for quality assurance in the industry across the globe. The quality assurance is prioritized in industries, particularly in food and beverage, to maintain consumer trust and compliance with regulatory standards. The proficiency testing ensures the dependability of laboratory testing procedures.
NGS Sample Preparation Market Size, Share &Trends Analysis Report by Product Class (Reagent and Consumables, and Workstations), by Application (Diagnostics, Drug Discovery, and Others) and by End-User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others), Forecast Period (2023-2030)
Published: Feb 2026
NGS sample preparation market is anticipated to grow at a significant CAGR of 14.7% during the forecast period (2023-2030).The market’s growth is attributed to the high demand for genome sequencing due to decreasing sequencing costs. Continuous efforts to minimize the overall cost of sequencing have aided in the growth of the NGS Sample Preparation Market. Streamlining library preparation methods helps to considerably reduce costs.
Skin Care Supplements Market Size, Share & Trends Analysis Report by Type (Chemical Supplements and Organic Supplements), by Product Type (Oral Supplements and Topical Supplements), by Formulation (Tablets, Capsules, Liquids, and Powders), by Application (Skin Aging, Skin Hydration, Acne and Blemishes, Skin Brightening and Others), and by Distribution Channel (Pharmacies, Supermarkets and E-Commerce), Forecast Period (2023-2030)
Published: Feb 2026
Skin care supplements market is anticipated to grow at a CAGR of 7.8% during the forecast period (2023-2030). The market is driven by the increasing middle age population, coupled with the rising age-related skin conditions including wrinkles, loose facial skin, skin sagging, and skin aging, which is projected to lift the demand for skin-related products. According to the World Health Organization, in 2030, the number of people 60 years and older will grow by 56%. By 2050, the global population of older people will more than double to 2.1 billion.
Gel Documentation Systems Market Size, Share & Trends Analysis Report by Products (Instruments, Software, and Accessories), by Detection Techniques (Ultra-Violet (UV), Chemiluminescence, and Fluorescence), by Application (Nucleic Acid Quantification, Protein Quantification, and Others), and by End-User (Clinical and Diagnostic Laboratories, Pharmaceutical Industry, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Gel documentation systems market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023-2030). The market’s growth is attributed to technological advancements. The advent of innovative technologies, such as the GelDoc Go Imaging System, helps to drive market growth by improving functionality and user experience. For instance, in May 2020, Bio-Rad Laboratories, Inc., launched its GelDoc Go Imaging System, a portable benchtop device for documenting nucleic acid and protein gels, stain-free blots and gels, and colorimetric blots.
Bioinformatics Market Size, Share & Trends Analysis by Product & Services (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis Structural Analysis and Bioinformatics Services), By Application (Metabolomics, Transcriptomics, Proteomics, Genomics and Others) Forecast Period (2025-2035)
Published: Feb 2026
Bioinformatics market was valued at $12.8 billion in 2024 and is projected to reach $44.9 billion by 2035, growing at a CAGR of 12.1% from 2025 to 2035. The bioinformatics industry growth is driven by increased R&D investments due to the growing need for advanced data analysis in genomics, personalized medicine, and drug discovery. Additionally, governments, biotech firms, and pharmaceutical companies are heavily funding bioinformatics research to accelerate innovations. For instance, Genomic analysis of conotruncal heart defects is a collaborative research grant funded by the DBT, Government of India to the IOB and Mazumdar Shaw Medical Centre (MSMC), Narayana Hrudayalaya for the project entitled “Genetics of syndromic and non-syndromic conotruncal heart defects”.
Automated Microscopy Market Size, Share & Trends Analysis Report by Product (Inverted Microscope, Fluorescence Microscope, Electron Microscope, Scanning Electron Microscopes (SEM), Optical Microscope, and Others), by Application (Life Sciences and Biomedical Research, Semiconductors, and Others), and by End-User (Hospitals and Healthcare Facilities, Academic and Research Institutions, Clinical and Diagnostic Laboratories, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Automated microscopy market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). The market’s growth is attributed to the development in scanning electron microscope (SEM) technology. The development of automation features, including "Simple SEM" photography, montaging, and live elemental analysis, indicates that scanning electron microscopy technology constantly progressing. Users seeking more effective and convenient tools for their research and applications are attracted by the aforementioned enhancements.
Cell Separation Technology Market Size, Share & Trends Analysis Report by Type (Instruments and Consumables), by Technology (Gradient Centrifugation, Surface Markers Separation, Filtration Based Separation, Immunodensity Cell Separation, and Others), by Application (Oncology, Neuroscience, Stem Cell Research, Microbiology, and Immunology), and by End Users (Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies and Hospitals & Diagnostic Laboratories) Forecast Period (2023-2030)
Published: Feb 2026
Cell separation technology market is anticipated to grow at a CAGR of 10.1% during the forecast period (2023-2030). Cell separation technology is a key part of many life sciences, from stem cell and oncology research to routine clinical diagnosis. The growing adoption of imaging and spectral technologies with the development across numerous fields is the key factor supporting the growth of the market globally.
Carrier Screening Market Size, Share & Trends Analysis Report by Type (Expanded Carrier Screening, and Targeted Disease Carrier Screening), by Medical Condition (Hematological, Pulmonary, Neurological, and Others), by Technology (DNA Sequencing, Polymerase Chain Reaction (PCR), Microarrays, and Others), and by End User (Hospitals and Clinics, Reference Laboratories, Government and Public Health Programs, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Carrier screening market is anticipated to grow at a CAGR of 17.1% during the forecast period (2023-2030). The market’s growth is attributed to development of comprehensive testing. The availability of the FirstGene 4-in-1 prenatal screening test is part of a wider effort to improve carrier screening and prenatal care. In response to the rising need for holistic genetic insights throughout pregnancy, this comprehensive test, that covers several aspects of prenatal health and genetics, is helping to boost the global carrier screening market.
Automated Sample Storage Systems Market Size, Share & Trends Analysis Report by Product (Automated Compound Storage System, System Unit, and Reagents & Consumables), by Sample Type (Biological Samples and Compound Samples), and by End-User (Pharmaceutical & Biotech Companies, Academic & Research Institutions, Diagnostic Labs, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Automated sample storage systems market is anticipated to grow at a CAGR of 10.1% during the forecast period (2023-2030). Automated sample storage systems are essential for preserving the integrity of a sample, preventing contamination, and maintaining the sample's chemical & physical properties. The growing adoption of versatile automation solutions with the improving compact and accessible system is the key factor supporting the growth of the market globally.
Optical Genome Mapping Market Size, Share & Trends Analysis Report By Offerings (Consumables, Instruments, Services, and Software), By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, and Others (Improving De Novo Plant Genome Assemblies, Identifying Genetic Abnormalities, Diagnosing Non-Haematological Cancers), And By End Users (Research & Academic Institutions, Biotechnology & Pharmaceutical Companies, Clinical Laboratories And Others (CRO)), Forecast Period (2025-2035)
Published: Feb 2026
Optical genome mapping market, estimated at $132 million in 2024, is projected to grow to $1.5 billion with a CAGR of 23.9% during the forecast period (2025–2035). Optical genome mapping used in the field of molecular cytogenetics has the potential to replace conventional testing methodologies in clinical diagnostics. The growing adoption of cytogenetic/molecular genetics technologies with improved standard diagnostics is the key factor supporting the growth of the market globally. Dubbed ‘New Generation Cytogenetics’, optical genome mapping, when compared to conventional diagnostic techniques, offers better resolution and can detect a wider range of genetic abnormalities. Hence, the market players are also focusing on introducing next-generation genetic testing tools that further bolster the market growth.
CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product Type (Vector-based Cas and DNA-free Cas), by Service Type (Cell Line Engineering, gRNA design, Microbial Gene Editing and DNA Synthesis), by Application (Genome Engineering, Disease Models, Functional Genomics and Other) and by End Users (Biotechnology Companies & Pharmaceutical, Academic and Government Research Institute and CROs), Forecast Period (2023-2030)
Published: Feb 2026
CRISPR and Cas genes market is anticipated to grow at a CAGR of 13.5% during the forecast period (2023-2030). CRISPR-Cas systems are the most widely used genome editing technology in molecular biology laboratories around the globe. The growing adoption of CRISPR-based screens with the improving genomic target is the key factor supporting the growth of the market globally.
Biobanks Market Size, Share & Trends Analysis Report by Equipment (Cryogenic Storage Systems, Refrigerators, Ice Machines, Freezers, Alarm Monitoring Systems, and Others), by Sample Type (Human Fluid, Cell, Human Tissue, and Organ, Nucleic Acids, and Other), and by Application (Therapeutic, Regenerative Medicine, Drug Discovery and Other), Forecast Period (2023-2030)
Published: Feb 2026
Biobanks market is anticipated to grow at a CAGR of 10.1% during the forecast period (2023-2030). Biobanks are structures in charge of the collection, storage, and provision of biological samples and their associated data. The growing adoption of biobank accelerate the shared understanding of the disease and play a crucial role in the global effort to overcome disease prevalence is the key factor supporting the growth of the market globally.
Upstream Bioprocessing Market Size, Share & Trends Analysis Report by Product (Bioreactors, Cell Culture Products, Filters, Bags and Containers and Others), by Workflow (Media Preparation, Cell Culture and Cell Separation), and by Use Type (Multi-Use and Single-Use), Forecast Period (2023-2030)
Published: Feb 2026
Upstream bioprocessing market is anticipated to grow at a CAGR of 11.1% during the forecast period (2023-2030). An increase in advantage of automated upstream bioprocessing such as improved process control, enhanced product quality, reduced variability, increased throughput and efficiency, and cost savings drive the growth of market. The growing adoption of automated upstream bioprocessing with improved software is the key factor supporting the growth of the market globally.
Single-Use Bioprocessing Market Size, Share & Trends Analysis Report by Product (Filtration Assemblies, Media Bags and Containers, Disposable Bioreactors, Disposable Mixers and Other), by Application (Filtration, Cell Culture, Purification and Other), and by End Users (Biopharmaceutical Manufacturers, Academic and Clinical Research Institutes and Other), Forecast Period (2023-2030)
Published: Feb 2026
Single-use bioprocessing market is anticipated to grow at a CAGR of 10.9% during the forecast period (2023-2030). Single-use bioprocessing technology is used in a broad range of biopharmaceutical applications, including filtration, mixing, purification, upstream expression, storage, and separation. The growing adoption of single use bioreactor coupled with advance technology is the key factor supporting the growth of the market globally.
In-vitro toxicology testing Market Size, Share & Trends Analysis Report, by Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS), by Method (Cellular Assay, Biochemical Assay, In Silica, Ex Vivo), by Application (Systematic Toxicology, Dermal Toxicity, Endorine Disruption, Occular Toxicity, Other Applications), by End-User (Pharmaceutical and Biotechnology, Diagnostics, Other End-Users) Forecast Period (2023-2030)
Published: Feb 2026
In-vitro toxicology testing market is anticipated to grow at a considerable CAGR of 10.5% during the forecast period. A considerable rise in pharmaceutical research expenditure is a key factor driving the growth of the in-vitro toxicology testing. Due to increased R&D expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for in-vitro toxicology testing.
Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Technology (CTC Detection and Enrichment Methods, CTC Direct Detection Methods, and CTC Analysis), By Product (Kits and Reagents, Blood Collection Tubes and Devices), and By End Users (Hospitals and Clinics, Research and Academic Institutes and Diagnostic Centers), Forecast Period (2023-2030)
Published: Feb 2026
Circulating tumor cells market is anticipated to grow at a CAGR of 12.5% during the forecast period (2023-2030). Circulating tumor cells (CTC) provide a blood biomarker for early carcinogenesis, cancer progression, and treatment effectiveness. The growing adoption of CTC assays has attracted intense interest as a biomarker that may assist in disease management and is acting as a key supporting factor for the growth of the market globally.
Microbial Fermentation Technology Market Size, Share & Trends Analysis Report by Technology (Fed-Batch Fermentation, Solid-State Fermentation, and Continuous Stirred-Tank Reactor), by Application (Antibiotics, Vaccines, Solvents, and Intermediary compounds), and by End-Users (Bio-Pharmaceutical Industries, Food and Feed Industries, CROs and CMOs, and Academic Research Institutes), Forecast Period (2023-2030)
Published: Feb 2026
Microbial fermentation technology market is anticipated to grow at a CAGR of 5.9% during the forecast period (2023-2030). The major factor driving the global microbial fermentation technology market growth includes the rising industrial fermentation, which is used to generate chemicals, materials, biofuels, meals, and medicines. The main purpose in adoption of fermentation technology is to alter the metabolic pathways using cultivation-based or molecular approaches.
SNP genotyping Market Size, Share & Trends Analysis Report by Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, and Other Techniques), End-User (Pharmacogenomics and Diagnostic Field) Forecast Period (2023-2030)
Published: Feb 2026
SNP genotyping market is anticipated to grow at a significant CAGR of 20.5% during the forecast period. The market is mainly driven by increasing R&D projects in genotyping domain, and rising funding in the biotechnology industry. The biopharmaceutical companies are investing heavily in the R&D projects, attributed to advances and discoveries. From genomics to personalized medicines, all the recent advancement has created significant scope in developing unique treatment options for various chronic diseases including Cancer, and other infectious diseases.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Size, Share & Trends Analysis Report by Type (Packed Columns and Capillary Columns), and by Application (Industrial Use, Laboratory Use, and Others), Forecast Period (2023-2030)
Published: Feb 2026
UHPLC columns market is anticipated to grow at a CAGR of 9.8% during the forecast period. The demand for UHPLC columns is driven by the high efficiency, speed, and sensitivity in effectively separating and identifying complex compound mixtures. This demand exceeds various industries such as pharmaceutical, biotechnology, food, and environmental industries. In addition, its fast and accurate results have increased the demand in the food, cannabis, pharmaceutical, and chemical industries.
Pharmaceutical Dissolution Testing Services Market Size, Share & Trends Analysis Report by Method (In-Vitro and In-Vivo), by Dosage Form (Capsules and Tablets), and by Dissolution Apparatus (Basket and Paddle) Forecast Period (2023-2030)
Published: Feb 2026
Pharmaceutical dissolution testing services market is anticipated to grow at a CAGR of 7.5% during the forecast period. Dissolution is a well-defined test with both instrumentation and testing methodology specified in great detail by the USP [US Pharmacopeia). So, for existing formulations there is not a lot of opportunity for innovation. A considerable rise in pharmaceutical research expenditure is a key factor driving the growth of the pharmaceutical dissolution testing services.
Gene Prediction Tools Market Size, Share & Trends Analysis Report by Product (CRISPR/Cas9, ZFNs, TALENs, Viral Systems, Transposon Systems, and Others), by Application (Veterinary Medicine, Cell Line Engineering, Bioremediation, Food and Brewing Development, Food Waste Management, and Bio Sensing Development), and by End User (Biotech and Pharma Companies, Academic and Research Institutes, and Food Industry) Forecast Period (2022-2030)
Published: Feb 2026
Gene prediction tools market is anticipated to grow at a CAGR of 18.3% during the forecast period. With the increasing emphasis on personalized medicines and precision healthcare, there is a rising demand for accurate gene prediction tools that assist in providing the impact of genetic variations on health and diseases. In order to cater to the rising demand, several market organization are focusing on launching new genome sequencing projectes which in turn to bolster the market growth.
Plant Phenotyping Market Size, Share & Trends Analysis Report, By Product Type (Equipment (By Automation Type (Fully Automated, Semi-Automated, and Manual), By Analysis System Type (Image Analysis Systems, Multispectral Scientific Cameras, Canopy Analysis Systems, Fluorometers, and Others), By Software (Data Acquisition, Image Analysis, and System Control), By Sensors (Image Sensors, NDVI Sensors, Temperature Sensors, and Others)), By Application (High-Throughput Screening, Trait Identification, Photosynthetic Performance, Morphology and Growth Assessment, and Others), Forecast Period (2022-2028)
Published: Feb 2026
Plant phenotyping market is anticipated to grow at a significant CAGR of 9.5% during the forecast period. The rising demand for food security is a primary factor driving the deployment of innovative technologies to accelerate crop production. Plant phenotyping methods have been emerging significantly over the years. Hyperspectral imaging has been applied to detect abiotic, biotic, and quality traits in plants in indoor and outdoor growing conditions.
Global Enzyme Market Size, Share & Trends Analysis Report By Type (Industrial And Specialty), By Product (Carbohydrase And Proteases), And By Source (Microorganisms, Plant, And Animals) Forecast Period (2025-2035)
Published: Feb 2026
The global enzyme market is anticipated to grow at a CAGR of 6.8% during the forecast period. Enzymes are substances that help speed up the chemical reactions in living organisms. They are essential for liver function, digestion, and other applications and are derived from the organs of animals, microorganisms, calf stomachs, and plant materials. They are used in textiles and detergents, pharmaceuticals and biotechnology R&D, food and animal feed, and manufacturing units. The growing awareness about health and chronic diseases such as digestive diseases and others and also increased the demand for functional food and beverages for better health has propelled the global enzyme market.
Digestive Health Enzymes Market Size, Share & Trends Analysis Report by Enzyme Type (Carbohydrase, Protease, Lipase, and Others), by Product Type (Single Enzyme Products, and Multi Enzymes Blend), by Origin (Animal, Microbial, and Plant), by Dosage Form (Capsules, Tablets, Powders, Liquids, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Digestive health enzymes market was valued at $660.2 million in 2025 and is projected to reach $1,121.1 million by 2035, growing at a CAGR of 5.6% during the forecast period (2026-2035). The global digestive health enzymes market is growing due to the increasing focus on digestive wellness and the rising prevalence of digestion-related discomfort linked to modern dietary patterns. Consumers are showing greater preference for targeted digestive solutions, supporting demand for both single enzyme products and multi-enzyme blends across key enzyme types such as carbohydrase, protease, and lipase. At the same time, the shift toward microbial and plant-based enzyme sources is strengthening market expansion, as these origins align with clean-label preferences and broader acceptance across dietary restrictions. Product innovation in dosage forms, including capsules and powders, is further improving consumer compliance and expanding usage across age groups.
Cancer Stem Cells Market Size, Share & Trends Analysis Report by Therapy (Targeted Cancer Stem Cells Therapy and Stem Cell-Based Cancer Therapy), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer and Other) and by Application (Drug Discovery, Diagnostics, Regenerative Medicine, Translational / Preclinical Research and Others), Forecast (2026-2035)
Published: May 2026
Cancer stem cells market was valued at $2.8 billion in 2025 and is projected to reach $6.8 billion by 2035, growing at a CAGR of 9.3% during the forecast period (2026-2035). The global cancer stem cells market is witnessing steady expansion, driven by advancements in targeted and stem cell-based therapies. Increasing research efforts to understand CSC biology are fueling the development of novel therapeutic approaches that address tumor recurrence and resistance. Growing investments in oncology R&D and the establishment of specialized treatment and manufacturing facilities are further supporting market growth. Additionally, the rising incidence of various cancers globally is creating a pressing need for innovative therapies that can improve patient outcomes. Collaborative initiatives between pharmaceutical companies, research institutions, and healthcare providers are accelerating the translation of CSC-focused treatments from the laboratory to clinical settings. With ongoing progress in drug discovery, diagnostics, and regenerative medicine, the market is positioned for sustained growth in the coming years.
Global Hematopoietic Stem Cell Transplantation Market Size, Share & Trends Analysis Report by Transplant Type (Allogenic, and Autologous), by Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Others) and by Application (Bone Marrow Transplant, Peripheral Blood Stem Cells Transplant, and Others) Forecast 2022-2028
Published: Feb 2026
The global hematopoietic stem cell transplantation market is anticipated to grow at a significant CAGR during the forecast period. This transplantation is a process that involves the intravenous infusion of allogeneic or autologous stem cells for reestablishing hematopoietic function in patients whose suffering from damaged or defective bone marrow or immune systems. One of the key factors that are boosting the market is the new studies and research on this transplant which has improved the process in the past few years. It solidifies confidence in the healthcare department to boost the market.
Global Gene Therapy Products Market Size, Share & Trends Analysis Report, By Product (Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine), By Application (Ophthalmology, Oncology, and Adenosine Deaminase Deficient Severe Combined Immunodeficiency (ADA-SCID)), Forecast (2021-2027)
Published: Feb 2026
The global gene therapy products market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Gene therapy is an advanced medical treatment involving the transfer of a normal/ healthy gene to replace a defective gene in a cell.
Global In Vivo Toxicology Market Size, Share & Trends Analysis Report By Type (Acute, Sub-acute, Sub-chronic, and Chronic Test Type), and by Toxicity End Point (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Development & Reproductive Toxicity, and Others) Forecast Period 2021-2027
Published: Feb 2026
The global in vivo toxicology market is anticipated to grow at a significant CAGR of over 4% during the forecast period. The increasing investments for R&D are one of the major driving factors for the in vivo toxicology market.
Global Veterinary Reference Laboratory Market, Size, Share, And Trend Analysis Report By Animal Type (Livestock Animals, Companion Animals), By Application (Clinical Pathology, Gynecology, Bacteriology, Toxicology, Others (Virology)), Forecast Period (2021-2027)
Published: May 2026
The global veterinary reference laboratory market is estimated to grow at a significant CAGR during the forecast period. The growing number of companion animals and the rise in zoonotic diseases globally are driving the market growth.
Microfluidics Market Size, Share & Trends Analysis By Component (Microfluidic Chips, Micro Pumps, Microneedles, Microfluidic Actuators, Microvalves, Microchannels, Microwells, And Others), By Material (Polymer, Silicon, Glass, Other Materials), By Application (Lab-On-A-Chip, Organs-On-Chips, Continuous Flow Microfluidics, Optofluidics, Acoustofluidics, Electrophoresis) And Forecast Period (2025-2035)
Published: Feb 2026
Microfluidics market was valued at $24,590 million in 2024 and is projected to reach $67,685 million by 2035, with a growing CAGR of 9.7% during the forecast period (2025-2035). Microfluidics are tools that can process micro or nano volumes of fluids to control chemical, biological, and physical changes. In recent years, research in microfluidics devices has risen significantly. The surge of usage of ICs in electronic devices has given significant growth to the microfluidics market globally. In the diagnosis industry, paper-based microfluidics is emerging as an effective multiplexable point-of-care platform.
Live Attenuated Vaccines Market Size, Share & Trends Analysis by Product Type (Viral Vaccines, and Bacterial Vaccines), By Indication (Tuberculosis, Measles, Mumps & Rubella (MMR), Rotavirus, Yellow Fever, Oral Polio, Influenza, and Others), By Route of Administration (Injectable, Oral, and Intranasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast Period (2026-2035)
Published: May 2026
Live attenuated vaccines market was valued at $30.2 billion in 2025 and is projected to reach $78.6 billion by 2035, growing at a CAGR of 10.1% during the forecast Period (2026-2035). The market is expanding steadily, driven by the increasing prevalence of infectious diseases and growing government-led immunization programs globally. Live attenuated vaccines, including MMR, rotavirus, and oral polio, offer strong, long-lasting immunity, often with fewer doses, making them essential in public health strategies. Technological advancements in vaccine development, formulation, and cold-chain logistics further support market growth. Rising awareness of preventive healthcare, coupled with expanding access in both developed and emerging regions, continues to fuel adoption and market expansion.
Oxidative Stress Assay Market Size, Share & Trends Analysis By Product (Reagents & Kits, Instruments, Consumables, And Services), By Assay Type (Reactive Oxygen Species (ROS) Assays, Antioxidant Capacity Assays, Enzyme-Based Assays, Indirect/Damage Markers ) By Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Chromatography, Microscopy, And Other Technologies) By Disease Type (Cardiovascular Disease, Respiratory Diseases, Cancer, Diabetes, Other Diseases, And Cell Culture / In Vitro Samples) and by End User (Pharmaceutical and biotechnology industries, Academic research institutes, Contract research organizations (CROs), Clinical laboratories, and Others) Forecast Period (2025-2035)
Published: Feb 2026
Oxidative stress assay market was valued at $1,254 million in 2024 and is projected to reach $3,295 million by 2035, growing at a CAGR of 9.2% during the forecast period (2025-2035). Oxidative stress is linked to chronic diseases such as cancer, cardiovascular, neurodegenerative disorders, and diabetes, driving demand for assays. Growing R&D investments, technological advancements, and focus on early diagnosis and personalized medicine make oxidative stress assays essential tools. The biotechnology industry expansion and government support accelerate market adoption. Additionally, growing public awareness of anti-aging and wellness drives demand for assays in the cosmetic and personal care industries.
US Agriculture Microbiome Market Size, Share & Trends Analysis Report by Function (Crop Protection, Soil Amendment), by Type (Bacteria, Fungi, Virus, Other), by Formulation (Dry Formulation, Liquid Formulation), by Mode of Application (Soil treatment, Foliar Spray, Seed Treatment), by Crop Type (Cereals, Oilseeds & Pulses, Fruits & Vegetables, Other) Forecast Period 2021-2027
Published: Feb 2026
US agriculture microbiome market is predicted to grow considerably at a CAGR of 11.8% during the forecast period (2021-2027). US is one of the leading countries in planting genetically modified crops, accounting for more than 40% of acres growing genetically modified crops across the globe.
UK Agriculture Microbiome Market Size, Share & Trends Analysis Report by Function (Crop Protection, Soil Amendment), by Type (Bacteria, Fungi, Virus, Other), by Formulation (Dry Formulation, Liquid Formulation), by Mode of Application (Soil treatment, Foliar Spray, Seed Treatment), by Crop Type (Cereals, Oilseeds & Pulses, Fruits & Vegetables, Other) Forecast Period 2021-2027
Published: Feb 2026
The UK agriculture microbiome market is predicted to grow considerably at a CAGR of 14.3% during the forecast period. The major factor augmenting the UK agriculture microbiome market includes a growing number of research activities that are supported by public and private funding.
North America Agriculture Microbiome Market Size, Share & Trends Analysis Report by Function (Crop Protection, Soil Amendment), by Type (Bacteria, Fungi, Virus, Other), by Formulation (Dry Formulation, Liquid Formulation), by Mode of Application (Soil treatment, Foliar Spray, Seed Treatment), by Crop Type (Cereals, Oilseeds & Pulses, Fruits & Vegetables, Other), Forecast Period (2026-2035)
Published: Feb 2026
North America agriculture microbiome market was valued at $5,110.7 million in 2025 and is projected to reach $18,493.4 million by 2035, growing at a CAGR of 13.8% during the forecast period (2026–2035). The agriculture microbiome market in North America is expanding as growers increasingly utilize microbial products to improve crop productivity and reduce chemical dependence. Corteva Agriscience has introduced microbial inoculants that enhance nutrient uptake and strengthen plant immunity across major crops such as corn and soybeans. Supportive government policies promoting sustainable agriculture are driving adoption. Research and field trials have demonstrated improvements in soil health and crop resilience. Collaboration between multinational companies and local distributors is broadening product accessibility.
European Agriculture Microbiome Market Size, Share & Trends Analysis Report by Function (Crop Protection, Soil Amendment), by Type (Bacteria, Fungi, Virus, Other), by Formulation (Dry Formulation, Liquid Formulation), by Mode of Application (Soil treatment, Foliar Spray, Seed Treatment), by Crop Type (Cereals, Oilseeds & Pulses, Fruits & Vegetables, Other), Forecast Period (2026-2035)
Published: Feb 2026
European agriculture microbiome market was valued at $2,056.8 million in 2025 and is projected to reach $8,075.0 million by 2035, growing at a CAGR of 14.8% during the forecast period (2026–2035). The agriculture microbiome sector in Europe is witnessing steady growth as farmers increasingly adopt microbial solutions to enhance crop productivity and reduce chemical inputs. BASF SE has introduced advanced microbial products that strengthen plant immunity and support sustainable farming practices. Regulatory initiatives promoting environmentally friendly agricultural inputs are encouraging broader adoption across the region. Field trials in major European crops such as cereals, fruits, and vegetables demonstrate measurable improvements in yield and soil health. Partnerships between multinational corporations and local distributors are expanding market accessibility. Together, these factors are driving consistent market expansion throughout Europe.
Asia-Pacific Agriculture Microbiome Market Size, Share & Trends Analysis Report by Function (Crop Protection, Soil Amendment), by Type (Bacteria, Fungi, Virus, Other), by Formulation (Dry Formulation, Liquid Formulation), by Mode of Application (Soil treatment, Foliar Spray, Seed Treatment), by Crop Type (Cereals, Oilseeds & Pulses, Fruits & Vegetables, Other), Forecast Period (2026-2035)
Published: Feb 2026
Asia-Pacific agriculture microbiome market was valued at $2,838.7 million in 2025 and is projected to reach $12.921.0 million by 2035, growing at a CAGR of 16.5% during the forecast period (2026–2035). The agriculture microbiome sector in Asia-Pacific is expanding as farmers increasingly adopt microbial solutions to enhance crop productivity and resilience. Sumitomo Chemical Co., Ltd. has introduced region-specific microbial formulations designed to improve plant growth and nutrient uptake in rice and horticultural crops. Rising awareness of sustainable farming practices, coupled with supportive government policies, is driving adoption across diverse agricultural landscapes. Field trials have demonstrated improvements in yield and soil health, encouraging wider usage. The integration of microbial products into conventional farming systems is becoming standard practice. This combination of innovation and regulatory support continues to strengthen market growth across the region.
Agriculture Microbiome Market Size, Share & Trends Analysis Report by Function (Crop Protection, Soil Amendment), by Type (Bacteria, Fungi, Virus, Other), by Formulation (Dry Formulation, Liquid Formulation), by Mode of Application (Soil treatment, Foliar Spray, Seed Treatment), by Crop Type (Cereals, Oilseeds & Pulses, Fruits & Vegetables, Other), Forecast Period (2026-2035)
Published: Feb 2026
Agriculture microbiome market was valued at $10,814.0 million in 2025 and is projected to reach $42,738.2 million by 2035, growing at a CAGR of 14.8% during the forecast period (2026-2035). The agriculture microbiome industry is expanding as growers increasingly recognize the value of microbial solutions in improving soil fertility and crop resilience. Companies such as Bayer AG have launched products like Biologicals by Bayer, which integrate microbial technologies to enhance nutrient absorption and plant vitality. Continuous research into microbial consortia and precision soil management has also strengthened the commercial scope of this market. As governments promote sustainable agricultural practices, adoption across cereals and horticultural crops continue to accelerate worldwide.
US Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals & Diagnostic Laboratories), Forecast Period 2026-2035
Published: Mar 2026
US cell counting market was valued at $662.7 million in 2025 and is projected to reach $1,223.3 million by 2035, growing at a CAGR of 6.4% during the forecast period (2026–2035). The US cell counting market is witnessing steady growth driven by increasing demand for accurate and reliable cell analysis in clinical, research, and industrial laboratories. Expansion of pharmaceutical and biotechnology research activities is contributing to higher adoption of cell counting instruments and consumables. Growing investment in healthcare infrastructure and modernization of diagnostic laboratories is further supporting market development. Advances in instrument design and integration with software solutions are enhancing workflow efficiency and data precision. Rising focus on regulatory compliance and standardized laboratory practices is reinforcing the uptake of advanced cell counting technologies. Additionally, increasing research in regenerative medicine, cell therapy, and immunology is creating sustained demand for high-quality analytical tools.
North American Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals & Diagnostic Laboratories), Forecast Period 2026-2035
Published: Mar 2026
North American cell counting market was valued at $683.9 million in 2025 and is projected to reach $1,254.7 million by 2035, growing at a CAGR of 6.4% during the forecast period (2026–2035). The North American Cell Counting Market is experiencing robust growth driven by increasing demand for precise and automated cellular analysis across clinical and research settings. Enhanced adoption of advanced instruments and consumables is fueling market expansion, particularly in pharmaceutical, biotechnology, and diagnostic sectors. Ongoing investments in life sciences research and development are further contributing to the rising utilization of cell counting technologies. Additionally, the escalating prevalence of chronic diseases necessitating accurate cell quantification supports sustained market growth. Strategic collaborations and technological innovations among key industry players continue to bolster the market trajectory through the forecast period.
Indian Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals & Diagnostic Laboratories), Forecast Period 2026-2035
Published: Mar 2026
Indian Cell Counting Market was valued at $56.8 million in 2025 and is projected to reach $116.6 million by 2035, growing at a CAGR of 7.5% during the forecast period (2026–2035). The Indian Cell Counting Market is witnessing steady growth supported by the expansion of pharmaceutical and biotechnology research activities across the country. Increasing investment in healthcare infrastructure and the establishment of advanced diagnostic laboratories are strengthening demand for reliable cell analysis solutions. Growth in contract research organizations and academic research institutes is further contributing to wider adoption of cell counting instruments and consumables. Technological improvements in laboratory equipment are enhancing accuracy and efficiency, encouraging modernization of existing facilities. Rising focus on clinical research, vaccine development, and cell-based studies is also supporting market expansion. Additionally, government initiatives promoting research, healthcare access, and domestic manufacturing are reinforcing long-term market growth.
European Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals & Diagnostic Laboratories), Forecast Period 2026-2035
Published: Mar 2026
European cell counting market was valued at $512.7 million in 2025 and is projected to reach $905.4 million by 2035, growing at a CAGR of 5.9% during the forecast period (2026–2035).
Asia-Pacific Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals and Diagnostic Laboratories), Forecast Period 2026-2035
Published: Mar 2026
Asia-Pacific cell counting market was valued at $470.8 million in 2025 and is projected to reach $899.7 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026–2035).
North American Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals and Clinics) Forecast Period 2026-2035
Published: Mar 2026
North American Biological Data Visualization Market was valued at $281.5 million in 2025 and is projected to reach $665.6 million by 2035, growing at a CAGR of 9.1% during the forecast period (2026–2035). The North American Biological Data Visualization Market is growing due to the rising adoption of advanced imaging and sequencing techniques across research institutes, hospitals, and pharmaceutical companies. Increased use of Magnetic Resonance Imaging, microscopy platforms, and high-throughput sequencing is generating complex datasets that require effective visualization tools. Expanding genomic analysis programs and deeper exploration of cell biology are reinforcing the need for software that can interpret multi-dimensional biological information. Investments in molecular and structural analysis are also driving demand for integrated visualization solutions that support discovery workflows.
European Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals, and Clinics) Forecast Period 2026-2035
Published: Mar 2026
European biological data visualization market was valued at $205.7 million in 2025 and is projected to reach $445.4 million by 2035, growing at a CAGR of 8.1% during the forecast period (2026–2035).
Asia-Pacific Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals and Clinics) Forecast Period 2026-2035
Published: May 2026
Asia-Pacific biological data visualization market was valued at $188.9 million in 2025 and is projected to reach $464.6 million by 2035, growing at a CAGR of 9.5% during the forecast period (2026–2035).
Japan Biotechnology Market Size, Share & Trends Analysis Report by Product (Instruments & Equipment, Reagents & Consumables, and Software & Services), by Technology (DNA Sequencing & Genomics, Cell Culture Technology, Nano biotechnology, Fermentation Technology, Chromatography & Separation, Tissue Engineering & Regenerative Medicine, CRISPR & Gene Editing, Proteomics & Protein Engineering, Bioinformatics, and Others) and by Application (Healthcare & Medical, Agriculture & Food, Industrial / Environmental and Marine Biotechnology), Forecast Period (2026-2035)
Published: Feb 2026
Japan biotechnology market was valued at $32.1 billion in 2025 and is projected to reach $59.5 billion by 2035, growing at a CAGR of 6.4% during the forecast period (2026–2035). The growth of Japan's biotechnology market is driven by advancements in healthcare, agriculture, and industrial processing are driving market changes. Local companies are investing strongly in innovative research as government policies are putting funding into the commercialization process. Collaboration between universities, academic institutions, and the industry is supporting research in the commercialization of the research process. Higher demand for biopharmaceuticals and gene therapies is another driver boosting growth. Japan's lead in precision medicine is reasserting the sector's significance.
Germany Biotechnology Market Size, Share & Trends Analysis Report by Product (Instruments & Equipment, Reagents & Consumables, and Software & Services), by Technology (DNA Sequencing & Genomics, Cell Culture Technology, Nano biotechnology, Fermentation Technology, Chromatography & Separation, Tissue Engineering & Regenerative Medicine, CRISPR & Gene Editing, Proteomics & Protein Engineering, Bioinformatics, and Others) and by Application (Healthcare & Medical, Agriculture & Food, Industrial / Environmental and Marine Biotechnology), Forecast Period (2026-2035)
Published: Feb 2026
Germany biotechnology market was valued at $54.8 billion in 2025 and is projected to reach $100.7 billion by 2035, growing at a CAGR of 6.3% during the forecast period (2026–2035). Germany's biotechnology market is driven by a strong infrastructure of research facilities and increasing contributions from the private sector. Companies are focusing on sophisticated applications in human and veterinary medicine, agriculture and animal feed, and industrial processes. The growth is propelled in part by the continuing need for new and innovative technologies that enhance medical treatments and more efficient production processes. German companies continue to solidify collaboration between academia and industry. This supports innovation, allowing more rapid uptake of new biotechnologies.
US Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026
Published: Feb 2026
US biotechnology market is estimated to grow significantly at a CAGR of 7.4% during the forecast period. The US biotechnology industry was valued at $200 billion in 2019 and anticpated to grow significantly during the forecast period.
UK Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026
Published: Feb 2026
UK biotechnology market is estimated to grow significantly at a CAGR of 7.1% during the forecast period UK has been one of the few economies which have witnessed technological transformation at a rapid rate in the past years. The increasing integration of healthcare with technology is augmenting the market in UK.
North American Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026
Published: Feb 2026
North American biotechnology market is estimated to grow significantly at a CAGR of 7.3% during the forecast period. The North American biotechnology industry was valued at $206 billion in 2019 and anticpated to grow significantly during the forecast period.
Indian Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026
Published: Feb 2026
Indian biotechnology market is estimated to grow significantly at a CAGR of 8.1% during the forecast period. The increasing healthcare expenditure and increasing funding in cell-based research in the country are further supporting the biotechnology market in the country.
European Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026
Published: Feb 2026
European biotechnology market is estimated to grow modestly, at a CAGR of 6.9%, during the forecast period. The European biotechnology industry was valued at $112 billion in 2019 and anticpated to grow significantly during the forecast period
Asia-Pacific Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026
Published: Feb 2026
Asia-Pacific biotechnology market is estimated to grow at a CAGR of 7.1% during the forecast period. The biotechnology industry in Asia-Pacific was valued at $94 billion in 2019 and anticipated to grow significantly during the forecast period.
Veterinary Reference Laboratory Market Size, Share & Trends Analysis Report, By Animal Type - Companion Animals, Livestock Animals, Aquaculture Animals, Research & Laboratory Animals, Wildlife & Zoo Animals, By Technology - Immunoassay Technologies, Molecular Technologies, Spectroscopy & Biochemistry Technologies, Microscopy-Based Technologies, Microbial Identification Technologies, Digital Pathology Technologies, By End User - Veterinary Hospitals, Veterinary Clinics, Animal Farms & Livestock Producers, Veterinary Research Institutes, Zoos & Wildlife Centers, Government Veterinary Agencies, Pet Diagnostic Service Providers, Forecast Period (2026-2035)
Published: May 2026
Veterinary reference laboratory market was valued at $5.1 billion in 2025 and is projected to reach $10.2 billion by 2035, expanding at a CAGR of 7.1% during the forecast period from 2026 to 2035. Rising pet ownership, increasing prevalence of zoonotic diseases, expansion of livestock disease surveillance programs, and rapid adoption of molecular diagnostic technologies are supporting long-term market growth globally. According to the World Health Organization (WHO), nearly 60% of known infectious diseases and around 75% of emerging infectious diseases originate from animals, highlighting the growing importance of veterinary diagnostics and reference laboratory testing worldwide. Increasing implementation of One Health initiatives integrating animal and public health surveillance is further accelerating demand for veterinary laboratory services.
Sample Preparation Market Size, Share & Trends Analysis Report, By Product Type (Instruments, Consumables, Services), By Technology (Liquid-Based, Solid-Phase Extraction, Magnetic Bead-Based, Filtration-Based, Centrifugation-Based), By Application (Proteomics, Genomics, Epigenomics, Other), By End-User (Academic & Research Institutes, Food & Environmental Testing Labs, Pharmaceutical & Biotechnology, Other End User), Forecast Period (2026–2035)
Published: Jun 2026
Global sample preparation market is valued at $8.39 billion in 2025 and is projected to reach $15.15 billion by 2035, expanding at a CAGR of 6.1% during the forecast period (2026–2035). Sample preparation is a critical step in analytical workflows, ensuring accurate and reproducible results across industries such as pharmaceuticals, biotechnology, food safety, and environmental testing. In recent years, the sample preparation market is influenced by European pharmaceutical R&D expenditure reaching approximately €50.1 billion annually, creating a high demand for advanced laboratory infrastructure. This growth is reinforced by the U.S. FDA’s stringent protocols for automated testing, which necessitate the adoption of high-throughput systems to ensure data integrity.
Cell Counting Market Size, Share & Trends Analysis Report by Technology (Electrical Impedance, Flow Cytometry-Based Counting, Spectrophotometry-Based), by Product Type (Instruments, Consumables & Accessories, Software), by Application (Research Applications, Clinical & Diagnostics, Bioprocessing & Production), by End-Use Industry (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Biopharmaceutical Manufacturing Facilities), and Forecast Period (2026–2035)
Published: May 2026
Cell counting market was valued at $10.2 billion in 2025 and is projected to reach $22.2 billion by 2035, growing at a CAGR of 8.1% from 2026 to 2035. This market plays a vital role in life sciences by enabling accurate quantification of cells across research, diagnostics, and biopharmaceutical manufacturing applications. Growing emphasis on biologics, cell and gene therapies, and regenerative medicine is significantly increasing the demand for precise and automated cell counting solutions. At the same time, the industry is undergoing a shift from traditional manual counting techniques toward advanced automated platforms, which improve workflow efficiency, reproducibility, and data accuracy in laboratory environments. Continuous technological advancements, including AI-enabled imaging systems, high-throughput flow cytometry, and integrated cell analysis platforms, are further enhancing real-time monitoring and analytical precision, thereby strengthening adoption across research and clinical workflows.
Optogenetics Market Size, Share & Trends Analysis Report By Product Type (Light Equipment, Actuators & Sensors, Instruments & Hardware, Consumables & Reagents, and Software & Data Analysis Platforms), By Technology Integration (Optogenetics with Electrophysiology, Optogenetics with Calcium Imaging, Optogenetics with AI-Based Neural Analysis, Optogenetics with CRISPR/Gene Editing, and Closed-Loop Optogenetic Systems), and By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Hospitals & Clinical Research Centers, and Government & Defense Research Organizations), Forecast Period (2026-2035)
Published: Jun 2026
Optogenetics market was valued at $788.3 million in 2025 and is projected to reach $2,482.6 million by 2035, registering a CAGR of 12.2% during the forecast period. Optogenetics combines optical stimulation and genetic engineering technologies to precisely control neuronal activity, making it a critical technology in neuroscience research, neural circuit mapping, and advanced brain disorder studies. Rising neurological disease prevalence worldwide is significantly supporting market expansion. According to the World Health Organization (WHO), neurological disorders affect more than 3 billion people globally and remain one of the leading causes of disability and mortality. Increasing research initiatives for neurological disorders such as epilepsy, Parkinson’s disease, Alzheimer’s disease, depression, and chronic pain are accelerating the adoption of optogenetics technologies across research laboratories and pharmaceutical companies.
Biotechnology Market Size, Share & Trends Analysis Report, By Product Type (Biopharmaceuticals, Biosimilars, Vaccines, Cell & Gene Therapy Products, Industrial Biotech Products, Research & Diagnostic Reagents), By Technology Type (Recombinant DNA Technology, Monoclonal Antibody Technology, Cell Therapy Technology, Gene Editing Technology, Fermentation Technology, Tissue Engineering), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Diagnostic Laboratories), Forecast Period (2026–2035)
Published: Jun 2026
Biotechnology market size is estimated at $1.5 trillion in 2025 and is projected to reach approximately $4.5 trillion by 2035, expanding at a CAGR of 11.5% during 2026–2035. The market growth is driven by increasing adoption of biologics, advancements in gene editing technologies, and expanding healthcare infrastructure globally. A key growth driver is the rising burden of chronic diseases and aging populations. According to the World Health Organization (WHO), non-communicable diseases account for nearly 74% of global deaths, significantly increasing demand for advanced therapies such as monoclonal antibodies and gene therapies. Additionally, the U.S. Food and Drug Administration (FDA) has accelerated approvals for biologics and gene therapies, with a growing pipeline of innovative treatments entering the market.
Nucleic Acid Labeling Market Size, Share & Trends Analysis Report By Label Type (Radioactive Labeling, Fluorescent Labels, Biotin-based Labels, Digoxigenin (DIG) Labels), By Application (DNA Sequencing, Fluorescence In Situ Hybridization (FISH), Microarrays, PCR & qPCR, Blotting Techniques (Southern/Northern)), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)), and Forecast Period (2026–2035)
Published: Jun 2026
Nucleic acid labeling market was valued at $1.2 billion in 2025 and is projected to reach $2.5 billion by 2035, registering a CAGR of 7.5% during the forecast period. This market is a fundamental component of molecular biology, as labeling techniques enable the detection, visualization, and quantification of DNA and RNA across a wide range of research and diagnostic applications. Increasing global investment in biopharmaceutical research, as indicated by the International Federation of Pharmaceutical Manufacturers & Associations, is significantly strengthening genomics and transcriptomics studies. The growing adoption of advanced technologies such as PCR, next-generation sequencing (NGS), and fluorescence-based detection methods is further driving the demand for nucleic acid labeling reagents and kits. These tools are essential for ensuring accuracy and sensitivity in molecular workflows, particularly in areas like disease diagnosis, drug discovery, and biomarker identification.
Protein Expression Market Size, Share & Trends Analysis Report, By Expression System (Prokaryotic Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Mammalian Cell Expression Systems, Cell-Free Expression Systems), By Product Type (Expression Vectors & Plasmids, Competent Cells, Expression Kits & Reagents, Instruments), By Application (Therapeutic Protein Production, Vaccine Development, Industrial Enzyme Production, Research & Academic Applications), By Workflow Stage (Gene Cloning & Vector Construction, Protein Expression, Protein Purification), Forecast Period (2026-2035)
Published: May 2026
Protein expression market size was valued at $3.05 billion in 2025 and is projected to reach $6.21 billion by 2035, growing at a CAGR of 7.37% between 2026 and 2035. The market comprises technologies and systems used for producing recombinant proteins essential in therapeutics, vaccines, and industrial enzymes. Protein expression plays a central role in biotechnology and pharmaceutical production, particularly in biologics manufacturing and drug discovery processes. A key driver supporting market growth is the increasing demand for biologics and recombinant therapeutics. According to the International Federation of Pharmaceutical Manufacturers & Associations, more than 50% of drugs under development globally are biologics, highlighting strong reliance on protein production systems. Additionally, the World Health Organization reports that chronic diseases account for over 70% of global deaths, driving demand for protein-based therapies such as monoclonal antibodies and vaccines.
Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals and Clinics) Forecast Period, (2026-2035)
Published: Mar 2026
Biological data visualization market was valued at $720.1 million in 2025 and is projected to reach $1,639.8 million by 2035, growing at a CAGR of 8.7% during the forecast period (2026-2035).
Bone Morphogenetic Protein (BMP) Market Size, Share & Trends Analysis Report by Product Type (Recombinant Human BMP-2, Recombinant Human BMP-7, Other BMP Variants), by Application (Spinal Fusion Surgeries, Dental Implants, Trauma & Fracture Healing), and Forecast Period (2026–2035)
Published: May 2026
Bone Morphogenetic Protein (BMP) market is poised for steady growth, with valuations expected to rise from $452.6 million in 2025 to $772.2 million by 2035, reflecting a CAGR of 5.6%. BMPs are essential biologics widely used in bone regeneration, particularly in spinal fusion and dental surgical procedures, due to their proven efficacy in promoting bone healing. The market’s expansion is being driven by the rising prevalence of bone disorders, an increasingly aging population, and growing awareness of advanced orthopedic therapies. Moreover, escalating healthcare expenditures, particularly in developed regions, along with ongoing advancements in regenerative medicine, are further accelerating the adoption of BMP-based therapies. Hospitals and specialized surgical centers remain key end-users, as they provide access to complex procedures and advanced biologics, ensuring higher procedural volumes and better patient outcomes.
Human Microbiome Market Size, Share & Trends Analysis Report By Product Type (Probiotics, Prebiotics, Synbiotics, Postbiotics, Others), By Technology (Prebiotics Sequencing, Metabolomics, Proteomics, bioinformatics and AI-based Analysis, Microbial Culturing), By Application (Therapeutics, Preventive Healthcare & Wellness, Diagnostics & Biomarker Discovery, Personalized Nutrition, Cosmetics & Dermatology), and Forecast Period (2026–2035)
Published: Jun 2026
Human microbiome market was valued at $1.6 billion in 2025 and is projected to reach $3.9 billion by 2035, expanding at a CAGR of 9.7%. The market includes a wide range of microbiome-based products such as probiotics, prebiotics, and live biotherapeutics, which are increasingly used across both healthcare and wellness sectors. Growth is primarily driven by rising awareness of gut health and its strong connection to immunity, metabolic function, and mental well-being. Additionally, the increasing prevalence of chronic diseases and a growing consumer shift toward preventive healthcare are significantly boosting demand. The emergence of personalized nutrition and microbiome-based diagnostics is further reshaping the industry landscape, while continuous advancements in sequencing technologies and bioinformatics are enabling more precise and targeted microbiome interventions.
Histology and Cytology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables & Reagents, and Software & Digital Solutions), By Test Type (Histology and Cytology ), By Application (Oncology, Infectious Diseases, Gynecological Screening, Non-Oncological Diseases), By End-Use Industry (Hospitals, Diagnostic laboratories, and Academic & research institutes), and Forecast Period (2026–2035)
Published: Jun 2026
Histology and cytology market was valued at $11.2 billion in 2025 and is projected to reach $19.3 billion by 2035, growing at a CAGR of 5.7% from 2026 to 2035. This market plays a critical role in disease diagnosis, particularly in cancer detection through detailed analysis of tissues and cells. Increasing focus on precision diagnostics and the expansion of large-scale screening programs are significantly driving global demand. Additionally, rising incidences of chronic diseases and cancer are further accelerating the need for accurate and early diagnostic solutions. Technological advancements, including automated staining systems, high-resolution slide scanners, and AI-powered pathology platforms, are transforming laboratory workflows. These innovations improve diagnostic accuracy, reduce turnaround time, and enhance overall efficiency, enabling healthcare providers to deliver faster and more reliable results across hospitals and diagnostic laboratories.
Nucleic Acid Isolation and Purification Market Size, Share & Trends Analysis Report, By Product (Kits & Reagents, Instruments, Consumables & Accessories), By Nucleic Acid Type (DNA Isolation & Purification, RNA Isolation & Purification), By Method / Technology (Magnetic Bead-Based Isolation, Column-Based Isolation, Reagent-Based Isolation), By Workflow Automation (Manual, Semi-Automated, Fully Automated), By Application (Molecular Diagnostics, Research Use, Drug Discovery), Forecast Period (2026-2035)
Published: May 2026
Nucleic acid isolation and purification Market size was valued at $7.4 billion in 2025 and is projected to reach $16.9 billion by 2035, growing at a CAGR of 8.8% between 2026 and 2035. The market includes technologies and consumables used for extracting and purifying DNA and RNA from biological samples such as blood, tissue, and cells. These solutions are critical in molecular diagnostics, genomics, drug discovery, and precision medicine applications. A major driver supporting market growth is the rapid expansion of molecular diagnostics and genomic research. According to the World Health Organization (WHO), infectious diseases and chronic conditions continue to require extensive diagnostic testing globally, driving demand for nucleic acid extraction workflows. Additionally, the U.S. Food and Drug Administration (FDA) has increased approvals for molecular diagnostic and companion diagnostic tests, further strengthening clinical adoption. The European Commission is actively supporting genomic data initiatives, enhancing the use of sequencing technologies in healthcare systems.
Biomaterials Market Size, Share & Trends Analysis Report by Type (Metallic, Polymeric, Ceramic, Composite) by Application (Orthopedic, Cardiovascular, Dental, Neurological, Ophthalmic, Wound Healing & Tissue Engineering), and Forecast Period (2026–2035)
Published: Apr 2026
Biomaterials market, valued at $45.1 billion in 2025, is projected to reach $85.3 billion by 2035, expanding at a CAGR of 6.7%. Biomaterials are integral to modern healthcare, enabling the development of implants, prosthetics, and regenerative solutions across orthopedic, cardiovascular, and dental applications. Rising incidences of chronic diseases, coupled with aging populations, are driving demand for advanced biomaterials that offer improved biocompatibility, durability, and performance. Innovations in tissue engineering and nanotechnology are further enhancing the integration of biomaterials with human tissues, supporting more effective patient outcomes. Growing healthcare expenditure and the adoption of high-performance, customized solutions are also key factors propelling long-term market growth.
Diagnostic Imaging Services Market Size, Share & Trends Analysis Report, By Imaging Modality (X-ray Imaging, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Nuclear Imaging, Mammography, and Other), By Technology Type (Analog Imaging, Digital Imaging, AI-Integrated Imaging Services, and Cloud-Based Imaging / Teleradiology), By Application (Oncology, Cardiology, Neurology, Orthopedics, Gynecology & Obstetrics, Pulmonology, Gastroenterology, and Others), Forecast Period (2026–2035)
Published: May 2026
Diagnostic imaging services market was valued at $530.0 billion in 2025 and is projected to reach approximately $930.0 billion by 2035, expanding at a CAGR of 5.8% from 2026 to 2035. The increasing burden of chronic diseases, an aging population, and rising demand for early disease diagnosis primarily drive market growth. According to the World Health Organization (WHO), non-communicable diseases account for nearly 74% of global deaths, significantly increasing the demand for imaging procedures such as CT, MRI, and ultrasound. Additionally, the OECD reports that diagnostic imaging utilization has increased by over 20% in developed economies over the last decade, highlighting the growing reliance on imaging services in clinical workflows. Major end-use industries include hospitals, diagnostic centers, and outpatient care facilities, where imaging services play a critical role in disease diagnosis, monitoring, and treatment planning. The adoption of digital imaging technologies, AI-assisted diagnostics, and teleradiology services is further enhancing operational efficiency and expanding access to imaging services globally.
Global Genetic Testing Services Market Size, Share & Trends Analysis Report by Type (Allogeneic and Autologous), By Application (Research and Therapeutics) and Forecast 2019-2025
Published: Feb 2026
The global Genetic Testing Services market is projected to have a considerable CAGR during the forecast period. The market growth mainly backed by the growing various chronic and infectious diseases such as cancer, infectious disease and others across the globe.
Global Food Biotechnology Market Size, Share & Trends Analysis Report by Type (Transgenic Biology and Synthetic Biology), by Application (Plants and Animals) Forecast Period (2019-2025)
Published: Feb 2026
Food biotechnology market is projected to grow at a considerable CAGR of over 10% during the forecast period (2019-2025). The increasing advancement in new technologies for developing new products through gene alteration of various plants, microbes, and animals is anticipated to be a major factor to drive the market growth. CRISPR is one such technology driving the food biotechnology market.
Global Oligonucleotide Synthesis Market Research By Product (Synthesized Oligonucleotides, Reagents, and Equipment), By Type (Custom Oligos and Predesigned Oligos), and By End-User (Hospitals, Pharmaceutical & Biotechnology Companies, Academic Research Institutes and Other) Forecast 2021-2027
Published: Feb 2026
The global oligonucleotide synthesis market is growing at a considerable CAGR of 11.0% during the forecast period. Increasing research activity, rising synthesis technological advancements are two of the prime factors affecting and driving the market.
Global Next Generation Sequencing Market Size, Share & Trends Analysis Report by Product Type (Reagents and Kits, Instruments, and Services), by Technology (Pyrosequencing, Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), Whole Genome Sequencing, RNA Sequencing, Targeted Resequencing, and Others), by Application (Drug Discovery, Genomic Research, Disease Diagnostics, Personalized Medicine, and Others) and by End-User (Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CRO), Hospitals and Clinics) and Forecast 2025-2035
Published: Feb 2026
The global next generation sequencing market is growing significantly, at a CAGR of around 16.4% during the forecast period (2019-2025). Next generation sequencing, also known as high-throughput sequencing technology is used to produce multiple sequence reaction in a cost-effective and rapid manner. The advent of next generation sequencing has led various collaborative projects, such as the MetaHIT and HMP using next generation sequencing as a foundational tool.
Global Glycomics/Glycobiology Market Size, Share & Trends Analysis Report by Product Type (Reagents and Kits, Instruments, Enzymes, and Carbohydrates), by Application (Drug Discovery and Disease Diagnostics) and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Clinics) and Forecast 2019-2025
Published: Feb 2026
The global glycomics/glycobiology market is growing significantly, at a CAGR of around 13.5% during the forecast period (2019-2025). Glycomics refers to the structural and functional analysis of glycomes present in biological systems and also identify genes that encode glycoproteins. There are various pivotal factors that are driving the global glycomics market, which includes the increasing focus on proteomics and glycomics research processes and rising demand for personalized medicines.
Global Cold pain Therapy Market Size, Share & Trends Analysis Report by Type (Prescription products and OTC products), By Application (Sports Medicine, Post-Trauma Therapy, Musculoskeletal Disorders, Post-Operative Therapy) and Forecast 2019-2025
Published: Feb 2026
The global market for cold pain therapy is estimated to have significant CAGR of XX% during the forecast period. The market is mainly driven due to increasing hip and knee replacement surgeries coupled with the aging population across the globe.
Global Cell Therapy Market Size, Share & Trends Analysis Report by Type (Allogeneic and Autologous), By Application (Research and Therapeutics) and Forecast 2019-2025
Published: Feb 2026
The global cell therapy market is projected to have considerable CAGR of XX% during the forecast period. The market is mainly driven due to the increasing clinical application of cell therapy and growing cell-based research across the globe.
Global Human Growth Hormone Market Size, Share & Trends Analysis Report by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Chronic Kidney Disease, Small for Gestational Stage and Others), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral) Forecast Period 2019-2025
Published: Feb 2026
The human growth hormone market is anticipated to grow at a significant CAGR during the forecast period. The market growth is attributed to the growing demand for human growth hormone for cosmetic treatment. Human growth hormone such as IGF-1 is widely used as an anti-aging treatment. This hormone can increase the thickness and flexibility of skin and reduction of wrinkles caused by ultraviolet rays. Hence, the growing aging population is expected to fuel the demand for human growth hormone globally.
Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report by Technology (Quantitative PCR and Digital PCR) by Product (Instruments, Reagents & Consumables, and Software & Services), Impact of COVID-19 on Global Digital PCR Industry, and Forecast 2019-2032
Published: Feb 2026
Global Digital PCR (dPCR) and Real-Time PCR (qPCR) products is expected to show a huge demand due to the COVID-19 pandemic all across the globe. PCR that is polymer chain reaction is an approach used for the detection of nucleic acid detection in order to measure the quantity of DNA or RNA in any specific sample.
Gene Editing Market Size, Share & Trends Analysis Report by Type (Reagents & Consumables, and Software & Systems), by Technology (CRISPR, TALENS, ZFN, Base Editing, Antisense, RNAI, Other Technologies), by Application (Cell Line Engineering, Genome Editing, Drug Discovery & Development, Other Applications), by End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROS & CDMOS, Other End Users) Forecast Period (2025-2035)
Published: Feb 2026
Gene editing market, valued at $4,852 million in 2024, grew to $5,245 million in 2025 and is projected to expand at a robust CAGR of 8.5% between 2025 and 2035, reaching an estimated value of $11,870 million by the end of the forecast period. The increasing digitalization of healthcare infrastructure has been contributing to the global market growth of gene editing. Gene editing is a revolutionary biotechnology that enables precise modifications to DNA, offering transformative potential across healthcare, agriculture, and research. Researchers are looking into using gene-editing as a treatment for a variety of diseases, such as cancer, heart disease, diabetes, AIDS, and Alzheimer's, to rare genetic disorders such as muscular dystrophy.
Global Single Cell Analysis Market Size, Share & Trends Analysis Report by Product (Electrostatic cleaning system, Water-based cleaning System and Robotic cleaning system), By Technology (Automatic and Manual), By Application (Residential and Commercial) and Forecast 2019-2025
Published: Feb 2026
The global single cell analysis market is estimated to grow at a significant CAGR of XX% during the forecast period. The market is mainly driven due to the increasing application of cell analysis in cancer research coupled with growing investment in cell based research.
Allergy Immunotherapy Market Size, Share & Trends Analysis Report by Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Drug Allergy, and Others), by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy), Forecast Period 2023-2030
Published: Feb 2026
Allergy immunotherapy market is anticipated to grow at a CAGR of 8.2% during the forecast period. Factor such as increasing awareness of allergies in patients is anticipated to propel the growth of the allergy immunotherapy industry. According to the World Allergy Organization, an increase in the pervasiveness of allergies has been witnessed and around 30% of the world population has allergic rhinitis.
Molecular Cytogenetics Market Size, Share & Trends Analysis Report by Product (Consumables, Software & Services, and Instruments), by Application (Cancer, Genetic Disorders, and Personalized Medicine), and by Technique (Fluorescence in Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), and Others) Forecast Period (2023-2030)
Published: Feb 2026
Molecular cytogenetics market is estimated to grow at a CAGR of 8.5% during the forecast period. The major factors contributing to the growth of the market include a significant prevalence of Cancer and increasing demand for genetic testing tools. As per the World Health Organization (WHO), the global Cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million mortality in 2018.
CAR T Cell Therapy Market Size, Share & Trends Analysis Report, By Application (Non-Hodgkin Lymphoma, Acute Lymphocytic Leukemia, and Others), By Target Antigen (CD19, CD22, and Others) Forecast Period (2022-2030)
Published: Feb 2026
CAR T cell therapy market is estimated to grow at a CAGR of 12.0% during the forecast period. The major factors contributing to the growth of the market include a significant prevalence of cancer across the globe and rising FDA approvals for cell and gene therapy. As per the World Health Organization (WHO), the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Around 43.8 million people were living with cancer in 2018 and were diagnosed within the last 5 years.
US Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
The US digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.1% during the forecast period. The US is anticipated to hold considerable market share in the global dPCR and qPCR market.
UK Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
UK digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.6% during the forecast period. UK is estimated to have a significant market for the dPCR and qPCR technology and solutions during the forecast period.
North American Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
North American digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.0% during the forecast period. The region holds a considerable share in the global dPCR and qPCR market and is analyzed on the basis of the countries including the US and Canada.
Japan Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
Japan digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.2% during the forecast period. Japan has a significant growth in the dPCR and qPCR market owing to the increase in the prevalence of infectious disease and development in healthcare infrastructure.
India Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
India digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 11.3% during the forecast period. India is one of the potential markets for dPCR and qPCR particularly due to the significant prevalence of cancer and CVD in the country.
Germany Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
Germany digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.0% during the forecast period. Germany is one of the major destinations for pharmaceutical R&D across the globe. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), the country invested nearly $8.3 billion in pharmaceutical R&D in 2017.
France Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
France digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.8% during the forecast period. France is one of the leading France biotech eco-systems along with Germany and UK. The increasing R&D in the life sciences sector is one of the major factors that is driving the growth of the market of dPCR and qPCR in the country.
European Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
European digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.6% during the forecast period. Europe is considered as one of the major regions in the global dPCR and qPCR market. The market in Europe is driven by an increasing prevalence of chronic diseases such as cancer and CVDs.
China Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
China digital PCR (dPCR) and real-time PCR (qPCR) market is estimated to grow at a CAGR of 9.3% during the forecast period. The market in China has both medium and long-term potential owing to the increasing prevalence of chronic diseases and the large aging population base.
Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
Published: Feb 2026
Asia-Pacific digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 9.1% during the forecast period. Asia-Pacific market has been witnessing considerable growth owing to the rise in the incidence of infectious diseases and genetic disorders such as cancer, HIV and hepatitis.
China Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
China liquid handling system market was valued at $488.9 million in 2025 and is projected to reach $1,112.7 million by 2035, growing at a CAGR of 8.6% from 2026 to 2035. The expansion of the market is being supported by increasing investments in laboratory automation across pharmaceutical, biotechnology, and clinical research environments. Rising demand for high-throughput screening and precision-based workflows is encouraging the adoption of advanced liquid handling technologies. Additionally, the strengthening of domestic manufacturing capabilities and technological advancements in robotics and software integration are contributing to sustained growth. Government initiatives aimed at enhancing healthcare infrastructure and research capabilities further reinforce market development. The growing focus on improving operational efficiency and minimizing human error in laboratory processes is also playing a significant role. Moreover, the presence of a large research base and continuous innovation in life sciences is fostering long-term market progression.
France Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
France liquid handling system market was valued at $184.1 million in 2025 and is projected to reach $389.1 million by 2035, growing at a CAGR of 7.8% from 2026 to 2035. The France Liquid Handling System market is experiencing steady growth driven by increasing investments in life sciences research and pharmaceutical development. Rising demand for automation in laboratory workflows has enhanced efficiency and reduced errors, encouraging adoption across both academic and industrial laboratories. Additionally, the expansion of the biotechnology and clinical research sectors is creating a consistent need for advanced liquid handling solutions. Regulatory emphasis on precision and reproducibility in experiments further supports market growth. The integration of smart technologies and digital interfaces into liquid handling systems is also attracting end users seeking higher productivity. Overall, these factors collectively contribute to the sustained development of the market in France.
Indian Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
Indian liquid handling system market was valued at $133.3 million in 2025 and is projected to reach $314.0 million by 2035, growing at a CAGR of 9.0% from 2026 to 2035. Growth in the Indian market is being supported by increasing adoption of automated laboratory technologies across pharmaceutical and biotechnology applications. Rising investments in research and development activities, particularly in drug discovery and diagnostics, are contributing to higher demand for precise and efficient liquid handling solutions. The expansion of contract research and manufacturing organizations is further strengthening the need for scalable and reliable laboratory workflows.
Japan Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
Japan liquid handling system market was valued at $233.4 million in 2025 and is projected to reach $512.4 million by 2035, growing at a CAGR of 8.2% from 2026 to 2035. The expansion of this market is supported by increasing integration of precision-driven laboratory workflows across pharmaceutical, biotechnology, and clinical research environments. Growing emphasis on accuracy and reproducibility in experimental processes has encouraged the adoption of advanced liquid handling technologies. In addition, the presence of a well-established life sciences infrastructure has contributed to sustained demand for automated and semi-automated systems. Continuous advancements in analytical instrumentation and laboratory automation are further strengthening operational efficiencies. The rising focus on high-throughput screening and diagnostic applications is also playing a significant role in shaping demand patterns. Moreover, ongoing investments in research and development activities continue to reinforce the market’s progression.
United States Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The US synthetic biology market is anticipated to grow at a CAGR of 31.8% during the forecast period. The synthetic biology market in the US is driven by extensive funding by government officials, increasing number of companies in the field of synthetic biology and technological advancements in the life science sector. Since the beginning of synthetic biology, the US has been conducting synthetic biology research for more than 15 years and has made progress.
UK Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The UK synthetic biology market is anticipated to grow at the CAGR of around 30.0% during the forecast period. Major factors that are expected to augment the market are funding by the government organization research carried out by various universities, and funding provided to the fellowship. As the market is yet to commercialize most of the market of synthetic biology is based on the research and development activities carried in the nation.
North American Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The North American synthetic biology market is anticipated to grow at a CAGR of 31.0% during the forecast period. The market growth is attributed to the increasing demand for bio-based products, rising R&D funding for synthetic biology, and increased investments by synthetic biology companies.
Latin America and Middle East Africa Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The LAMEA synthetic biology market is anticipated to grow at a CAGR of more than 30.0% during the forecast period. In Brazil, a university called the University of Sao Paulo (USP) h USP SynBio has been established that is promoting R&D in that region. The Synthetic Biology Center is being set-up with the objective to bring researchers from all disciplines of biomechanical engineering, chemistry, biosciences, engineering and statistics for synthetic biology.
Japanese Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The Japanese synthetic biology market is expected to grow at a significant rate during the forecast period. In synthetic biology, Japan is one of the leading Asian countries. In Japan, the studies are conducted under the name of synthetic biology at an independent administrative organization, RIKEN, and some universities in Japan. The synthetic biology in Japan is promoted by organizing competitions for undergraduates.
Indian Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The Indian synthetic biology market is anticipated to grow at a CAGR of more than 32.0% during the forecast period. The major factor that is contributing to the favor of the Indian synthetic biology market is that it is one of the fastest-growing economies across the globe. The potential of India in the field of Biotechnology and Synthetic biology is still untapped. It is due to the lack of awareness.
Germany Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The Germany synthetic biology market is anticipated to grow at a CAGR of 32.0% during the forecast period. The Germany synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling product, core product, and enabled product. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and xeno nucleic acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D.
France Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The France synthetic biology market is anticipated to grow at the CAGR of around 33.0% during the forecast period. Major opportunities for the France synthetic biology market is the presence of numerous companies and specially related to synthetic bio-fuels. Number of companies and start-ups are working toward synthetic biology including Global Bioenergies, DNA Script, Deinove and Fermentalg.
European Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The European synthetic biology market is anticipated to grow at the CAGR of 31.8% during the forecast period. Major European economies contributing in the market are the UK, Germany and France. Various biotech companies are working in the field of synthetic biology in these economies. Additionally, several associations have been established in the region for providing better environment in research and development.
China Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The China synthetic biology market is expected to grow at a significant rate during the forecast period. In China, the synthetic biology market is still at its nascent stage, with emerging development in the biotechnology field. Major factors that are expected to fuel the market growth are due to the funding provided by the Chinese government on various projects related to synthetic biology, including Artificial Synthetic Cell Factory and Minimal genome of E. coli and its synthesis.
Asia-Pacific Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025
Published: Feb 2026
The Asia-Pacific synthetic biology market is expected to grow at a CAGR of 35.0% during the forecast period. The initiatives by major economies in the field of synthetic biology is one of the factors that is promoting technological innovations in the Asia-Pacific region.
Japan Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
Japan cancer biomarkers market is growing at a CAGR of around 11.9% during the forecast period. Japan market for biomarkers is expected to witness positive growth during forecast period. The mortality rate in Japan due to cancer is increasing day by day. The reason for mortalities due to cancer tobacco smoking. The increasing prevalence of cancer holds a promising market for biomarkers in Japan for the treatment of cancers.
UK Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
UK cancer biomarker market is expected to grow at a CAGR of around 11.7% during the forecast period. The major factor that are increasing the market are high prevalence of cancer in the region, well-developed healthcare infrastructure and presence of major market player in the nation. Additionally, as the country have developed economy, per capita healthcare investment from government and public is higher than other developing nation and hence significant research can be observed in the near future.
North American Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
North American cancer biomarker market is growing at a CAGR of around 11.8% during the forecast period. The North American market for cancer biomarker is a significant market and is analyzed on the basis of country as the US and Canada. Factors that are contributing significantly in the market growth includes research and development, and high healthcare expenditure and so on.
US Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
US cancer biomarker market is anticipated to grow at a CAGR of 11.8% during the forecast period. The US cancer biomarker market in the North American region is dominating due to various factors such as investments in research and development, high healthcare expenditure, presence of key players and rising prevalence of cancer patients.
European Cancer biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
European cancer biomarker market is projected to grow at CAGR of 11.6% during the forecast period. The Europe is considered to be one of the dominating regions in the cancer biomarker market as it has a high healthcare expenditure and infrastructure. Major factor contributing to the cancer biomarker market are high prevalence of cancer, high per capita healthcare expenditure and high awareness towards cancer in the region.
Germany Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
Germany cancer biomarker market is anticipated to grow at a CAGR of 11.8% during the forecast period. Germany has well developed healthcare system and favorable government policies which are driving the global cancer biomarker market in the region. Adoption of specialized procedures to treat cancer, extensive R&D in the cancer treatments and presence of globally renowned major hospitals, research centers and clinics are contributing to the growth of the market.
Indian Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
Indian cancer biomarker market is expected to grow at a CAGR of around 12.0% during the forecast period. India is a strong market for cancer biomarkers particularly due to its large population base and large mortality due to cancer. Global cancer biomarker market has huge scope in India as biomarker development will enable in screening of large populations.
Latin America Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
Latin America cancer biomarkers market is growing at a CAGR of around 11.1% during the forecast period. The significant increase in prevalence of cancer is the major factor behind fueling the Latin America cancer biomarker market. Change in life style, vulnerability to various infectious disease, lack of awareness about the disease and lack of infrastructure are the major reason attributed for the prevalence of cancer.
Canada Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
Canada cancer biomarker market is growing at a CAGR of 11.4% during the forecast period. The healthcare industry of the Canada depends heavily on the demand created by the publicly funded and insured health care system of the country. The medical device industry consists of companies that produce a wide range of products which are used for the diagnosis and treatment of ailments.
China Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
China cancer biomarkers market is growing at a CAGR of around 11.8% during the forecast period. China has a strong market for cancer biomarkers due to huge government investments in R&D and Life Science projects, prevalence of cancer and increasing adoption of personalized medicine. All these factors are contributing to the growth of China cancer biomarker market.
Asia-Pacific Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker, and Protein Biomarker), by Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, and Other), by Applications (Drug Discovery and Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period 2019-2025
Published: Feb 2026
Asia-Pacific cancer biomarkers market is growing at a CAGR of around 11.9% during the forecast period. APAC is both a strong and promising market for biomarkers. This is particularly due to the strong population base, high prevalence of cancer in Asian countries such as China, Japan.
Asia-Pacific Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
Asia-Pacific liquid handling system market was valued at $1.1 billion in 2025 and is projected to reach $2.5 billion by 2035, growing at a CAGR of 8.5% from 2026 to 2035. The Asia-Pacific region is experiencing steady expansion driven by increasing laboratory automation across research and clinical environments. Rising investments in life sciences infrastructure and the growing presence of biotechnology and pharmaceutical activities are supporting the adoption of advanced laboratory technologies. Additionally, improvements in healthcare systems and a stronger focus on diagnostic accuracy are contributing to higher demand for precise fluid handling solutions. Academic and research institutions are also enhancing their experimental capabilities, further supporting market development. The availability of skilled professionals and evolving regulatory frameworks continues to facilitate technology integration. Collectively, these factors are contributing to sustained regional growth.
European Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
European liquid handling system market was valued at $1.3 billion in 2025 and is projected to reach $2.8 billion by 2035, growing at a CAGR of 8.0% from 2026 to 2035. Growth in the European market is being supported by the steady expansion of life sciences research and laboratory automation initiatives across academic and industrial settings. Increased emphasis on precision, reproducibility, and high-throughput workflows is encouraging laboratories to adopt advanced liquid handling technologies. In addition, the presence of well-established pharmaceutical and biotechnology sectors continues to drive demand for efficient sample preparation solutions. Regulatory focus on quality standards and data accuracy further contributes to the uptake of automated systems. Ongoing investments in research infrastructure and innovation capabilities across the region are also reinforcing market development. Collectively, these factors are shaping a favorable environment for sustained adoption and technological advancement.
Germany Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
Germany liquid handling system market was valued at $302.4 million in 2025 and is projected to reach $653.2 million by 2035, growing at a CAGR of 8.0% from 2026 to 2035. The expansion of the market is primarily supported by the increasing adoption of laboratory automation across research and clinical settings. Rising investments in life sciences, particularly in biotechnology and pharmaceutical development, are further strengthening demand for advanced liquid handling technologies. Additionally, the presence of well-established research institutions and a strong emphasis on precision-driven workflows contribute to sustained growth. Continuous technological advancements, including integration with digital platforms and improved accuracy, are also enhancing system adoption. Furthermore, growing requirements for high-throughput screening and reproducibility in experiments are encouraging laboratories to upgrade existing infrastructure. Collectively, these factors are fostering a stable and progressive market environment across the region.
North American Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
North American liquid handling system market was valued at $2.0 billion in 2025 and is projected to reach $4.4 billion by 2035, growing at a CAGR of 8.3% from 2026 to 2035. Growth in the North American market is being supported by sustained advancements in laboratory automation technologies and the increasing integration of precision-driven workflows across research and clinical settings. The presence of well-established life sciences and biotechnology sectors continues to encourage the adoption of sophisticated liquid handling solutions. In addition, rising investment in drug discovery and molecular diagnostics is reinforcing the demand for high-throughput and reproducible laboratory processes. Academic and research institutions are also contributing to market expansion through continuous innovation and technology adoption. Furthermore, regulatory emphasis on accuracy and standardization in laboratory procedures is promoting the use of automated systems. The overall ecosystem, supported by strong infrastructure and skilled expertise, is creating favorable conditions for steady market development.
UK Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
UK liquid handling system market was valued at $210.3 million in 2025 and is projected to reach $437.3 million by 2035, growing at a CAGR of 7.6%from 2026 to 2035. The expansion of the UK liquid handling systems market is being supported by increasing laboratory automation across pharmaceutical, biotechnology, and clinical research environments. Growing emphasis on precision, reproducibility, and high-throughput workflows is encouraging the adoption of advanced liquid handling technologies. In addition, sustained investment in life sciences research and drug development activities is contributing to the demand for efficient laboratory solutions. The presence of well-established research institutions and innovation hubs further strengthens market progression. Regulatory focus on quality standards and data accuracy is also influencing technology uptake. Collectively, these factors are fostering steady development within the market landscape.
US Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
US liquid handling system market was valued at $1.8 billion in 2025 and is projected to reach $4.1 billion by 2035, growing at a CAGR of 8.3% from 2026 to 2035. Growth in the United States liquid handling system market is being supported by the increasing integration of automation within laboratory workflows, particularly across clinical diagnostics and life sciences research settings. The rising demand for high-throughput screening and precision-based experimentation is encouraging laboratories to adopt advanced liquid handling technologies. In addition, the expansion of pharmaceutical and biotechnology research activities is contributing to sustained equipment demand. Academic and research institutions are also investing in modern laboratory infrastructure, further supporting market expansion. Technological advancements, including improved accuracy and reproducibility, are enhancing the value proposition of these systems. Moreover, the growing emphasis on reducing manual errors and improving operational efficiency continues to drive adoption across diverse end-user segments.
US Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
US freeze-drying market was valued at $757.3 million in 2025 and is projected to reach $1,633.5 million by 2035, growing at a CAGR of 8.0% during the forecast period (2026–2035). The US freeze-drying market is experiencing sustained expansion, supported by rising demand from the pharmaceutical and biotechnology sectors for stable, shelf?life?extended formulations. Increasing production of injectable biologics and specialty drugs has strengthened the need for advanced lyophilization capabilities across manufacturing facilities. Growth in clinical research activities and contract development services is further contributing to equipment and process adoption. In addition, the food industry’s focus on premium, minimally processed products with extended storage stability is reinforcing commercial demand. Technological improvements in automation, energy efficiency, and process control are encouraging facility upgrades and capacity expansion. Collectively, these factors are shaping a favorable operating environment for freeze?drying solution providers across the US.
UK Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
UK freeze-drying market was valued at $133.5 million in 2025 and is projected to reach $273.5 million by 2035, growing at a CAGR of 7.5% during the forecast period (2026–2035). The UK freeze-drying market is experiencing steady growth driven by increasing demand across pharmaceutical, biotechnology, and food processing sectors. Advancements in lyophilization technologies, including tray and manifold freeze dryers, are enhancing operational efficiency and product quality. Rising adoption of industrial and pilot-scale freeze-drying systems is supporting large-scale production needs while maintaining precision and consistency. Additionally, innovations in vacuum, monitoring, and clean-in-place systems are improving automation and reducing downtime. Growing regulatory compliance requirements for drug stability and long-term storage are further fueling market expansion. The integration of advanced control systems and scalable solutions is enabling manufacturers to optimize productivity and meet evolving industry standards.
North America Freeze-Drying Market Size, Share & Trends Analysis by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period 2026-2035
Published: Mar 2026
North America freeze-drying market was valued at $831.5 million in 2025 and is projected to reach $1,775.6 million by 2035, growing at a CAGR of 7.9% during the forecast period (2026–2035). The North American market is experiencing steady expansion, supported by increasing industrial investments and technological advancements across key sectors. Rising demand for high-quality processing solutions in pharmaceuticals, biotechnology, and food applications is contributing to sustained growth. Companies are enhancing production capabilities and strengthening regional supply chains to meet evolving regulatory and performance standards. Ongoing modernization of manufacturing facilities and the adoption of automated systems are further reinforcing market momentum. In addition, strategic collaborations and capacity expansions across the United States and Canada are improving operational efficiency. These combined factors continue to create a favorable environment for long-term market development across the region.
Japan Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
Japan freeze-drying market was valued at $171.9 million in 2025 and is projected to reach $397.1 million by 2035, growing at a CAGR of 8.8% during the forecast period (2026–2035). The Japan freeze-drying market is experiencing steady growth driven by increasing demand across the pharmaceutical, biotechnology, and food processing sectors. Advancements in freeze-drying technologies, such as tray and manifold systems, are enhancing operational efficiency and product stability. The rising adoption of automated and controlled freeze-drying solutions is enabling precise processing, minimizing product loss, and improving throughput. Additionally,
Italy Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
Italy freeze-drying market was valued at $70.9 million in 2025 and is projected to reach $156.3 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026–2035). The Italy freeze-drying market is experiencing steady growth driven by increasing demand from the pharmaceutical and biotechnology sectors, particularly for the preservation of sensitive biological products. Advances in freeze-drying technology, including enhanced automation and energy-efficient systems, are enabling higher throughput and more precise control over processing conditions. The expanding food and nutraceutical industries are also contributing to market growth by adopting lyophilization to extend shelf life and maintain product quality.
Indian Freeze Drying Market Size, Share & Trends Analysis Report by Product (Dryer (Sub Segmented into Tray-Style Dryers, Rotary Freeze Dryers, and Manifold Freeze Dryer) and Accessories (Sub Segmented into Drying Chamber, Vacuum System, CIP (Clean-in-place) Systems, and Others), By Scale Of Operation (Industrial Scale Freeze Dryers, Pilot-Scale Freeze Dryers, and Lab Scale Freeze Dryers), and by End-User (Biopharmaceutical Companies, Food and Beverage Companies, Academic and Research Institutes, CRO & CMO, Hospitals, and Research Laboratories) Forecast Period (2025-2035)
Published: Feb 2026
Indian freeze drying market was valued at $92 million in 2024 and is projected to reach $229 million in 2035, growing at a CAGR of 8.7% during the forecast period (2025-2035). Freeze drying is a dehydration process for the preservation of perishable products by extending their shelf life and enhancing transportability. As the incidence of chronic and infectious diseases continues to grow, healthcare institutions are increasingly embracing lyophilized formulations owing to their consistency and long-term storage advantage. Increasing the need for lyophilized pharmaceuticals, especially for injectables and biologics, is likely to propel the huge growth of the Indian freeze-drying market. For instance, in January 2025, Akums Drugs and Pharmaceuticals released a new facility for manufacturing injectables and lyophilized products for improving drug stability and shelf life. The operations of the company also consist of manufacturing vials, ampoules, eye and ear drops, and form-fill-seal (FFS) products.
Germany Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
Germany freeze-drying market was valued at $202.7 million in 2025 and is projected to reach $441.8 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026–2035). The Germany freeze-drying market is experiencing steady growth driven by increasing demand across the pharmaceutical, biotechnology, and food industries. Advances in process automation and precision control technologies are enhancing the efficiency and reliability of freeze-drying operations. Rising adoption of laboratory and pilot-scale freeze-dryers for research and development activities is contributing to market expansion. The emphasis on maintaining product stability and extending shelf life is encouraging investment in modern freeze-drying systems. Additionally, regulatory compliance and quality standards in the pharmaceutical sector are promoting the deployment of advanced freeze-drying solutions. Continuous innovation in equipment design and energy-efficient systems is further supporting the growth trajectory of the market.
France Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
France freeze-drying market was valued at $92.5 million in 2025 and is projected to reach $208.9 million by 2035, growing at a CAGR of 8.5% during the forecast period (2026–2035). The France freeze-drying market is demonstrating consistent growth supported by expanding pharmaceutical manufacturing and biotechnology research activities. Increasing focus on product stability and extended shelf life is encouraging the adoption of advanced drying technologies. Manufacturers are investing in modern systems that improve operational precision and reduce energy consumption. The rise in biologics and specialty drug production is further strengthening equipment demand. Research institutions and contract development facilities are also contributing to higher utilization of laboratory and pilot-scale systems. Continuous technological refinement and compliance with strict quality standards are sustaining long-term market expansion.
European Freeze-Drying Market Size, Share & Trends Analysis by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period 2026-2035
Published: Mar 2026
European freeze-drying market was valued at $695.4 million in 2025 and is projected to reach $1,502.8 million by 2035, growing at a CAGR of 8.1% during the forecast period (2026–2035). The European market is experiencing sustained growth, supported by rising industrial output and expanding cross-border trade activities. Increasing capital investment across manufacturing and technology-driven sectors has strengthened production capabilities and improved operational efficiency. Regulatory alignment within the region has further facilitated smoother commercial operations and enhanced investor confidence. In addition, infrastructure modernization and the adoption of advanced processing technologies are contributing to higher productivity standards. Growing emphasis on quality assurance and compliance has also reinforced market stability. Collectively, these structural and economic factors are supporting steady expansion across the region.
China Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
China freeze-drying market was valued at $244.7 million in 2025 and is projected to reach $603.6 million by 2035, growing at a CAGR of 9.5% during the forecast period (2026–2035). The China freeze-drying market is experiencing steady growth driven by expanding pharmaceutical, biotechnology, and food processing industries. Rising production of vaccines, biologics, and specialty drugs is increasing demand for high-performance freeze-drying equipment. Investments in automation and precision control systems are improving efficiency and product quality. Laboratory and pilot-scale freeze-dryers are being increasingly adopted for research and formulation development. Energy-efficient designs and modular equipment are gaining attention to optimize operational costs. Continuous innovation and focus on regulatory compliance are supporting the overall expansion of the market across multiple sectors.
Canada Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
Canada freeze-drying market was valued at $74.0 million in 2025 and is projected to reach $142.0 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026–2035). The Canada freeze-drying market is experiencing steady growth driven by increasing demand from the pharmaceutical, biotechnology, and food processing sectors. Rising production of vaccines, biologics, and specialty therapeutics is fueling the need for advanced freeze-drying systems. Companies are investing in automated and energy-efficient equipment to improve process reliability and operational efficiency. Laboratory and pilot-scale freeze dryers are seeing higher adoption for research and formulation development. Regulatory requirements and quality standards are encouraging the use of precise and controlled drying technologies. Continuous innovation in system design and monitoring capabilities is supporting the overall expansion of the market.
Asia-Pacific Freeze-Drying Market Size, Share & Trends Analysis Report by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period 2026-2035
Published: Mar 2026
Asia-Pacific freeze-drying market was valued at $661.3 million in 2025 and is projected to reach $1,588.4 million by 2035, growing at a CAGR of 9.2% during the forecast period (2026–2035). The global market is experiencing sustained expansion, supported by increasing industrial adoption and continuous technological refinement across key application areas. Growing investment in advanced manufacturing infrastructure and process optimization has further reinforced this upward trajectory. Rising demand for high-quality, stable, and long-shelf-life products across multiple end-use sectors is also contributing to market acceleration. In addition, regulatory emphasis on quality standards and production efficiency is encouraging organizations to modernize their operational capabilities. Strategic capacity enhancements and cross-border commercial activities are strengthening supply networks worldwide. Collectively, these structural and operational factors are driving consistent growth at the global level.
US Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
The
US Biological Sample Handling market is expected to grow at a CAGR of around
8.2% during the forecast period. The US is the leader in the biological sample
handling market attributed to the presence of major life science companies such
as Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Becton, Dickinson
and Co., and rising R&D spending in the region.
UK Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
UK
Biological Sample Handling market is expected to grow at a CAGR of around 9.3%
during the forecast period. UK is expected to have a significant share in the
global biological sample handling market. The major factor that is augmenting
the market is high prevalence of chronic diseases in the country such as
cancer, CVD and so on.
North American Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
North
American Biological Sample Handling market is expected to grow at a CAGR of
around 8.2% during the forecast period. North America is the strongest
economies globally and has a well-developed healthcare infrastructure. North
American biological sample handling market has remarkable growth opportunities
in the growing biotechnology industry.
Japan Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
Japan
Biological Sample Handling market is expected to grow at CAGR of around 9.0%
during the forecast period. The Japanese pharmaceutical industry is competitive
in R&D capability. Japanese pharmaceutical companies have continued to
increase their investments in R&D for the discovery and development of
innovative new drugs every year, which represent more than 17% of total net
sales.
India Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
India
Biological Sample Handling market is expected to grow at CAGR of around 9.5%
during the forecast period. India is one of the fastest-growing economies
across the globe; and thus, contributes considerably to the biological sample
handling market. There major factors driving the market growth include the
increasing per capita healthcare expenditure and increasing funding in
biotechnology research in the country.
Germany Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
German
Biological Sample Handling market is expected to grow at a CAGR of around 8.2%
during the forecast period. Germany is one of the leading medical biotech nations
which makes it a promising market for biological sample handling.
European Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
The
European biological sample handling market is forecast to grow at a CAGR of
around 8.4% during the forecast period. Europe is expected to share
significantly in the global biological sample handling market owing to the
well-developed healthcare sector, and significant research in the field of
geniomics and protecomics in its economies such as UK, Germany, Italy, Spain
and many more.
China Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
China
Biological Sample Handling market is expected to grow at CAGR of around 9.7%
during the forecast period. China’s market has both medium and long-term
potential in the biological sample handling market in the life science
industry.
Asia-Pacific Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others) by Ownership (Commercial, and Academic/Research) Forecast Period 2019-2025
Published: Feb 2026
Asia-Pacific
Biological Sample Handling market is expected to grow at CAGR of around 9.3%
during the forecast period. Asia-Pacific is estimated to be a potential market
for biological sample handling due to the increasing R&D and investments by
government organizations in life science research.
Asia-Pacific 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The Asia-Pacific 3D cell culture market is expected to witness a significant growth with the CAGR of 18.2% during the forecast period. The market growth in the region is increasing owing to the high prevalence of different types of cancer, rising drug discovery initiatives among pharmaceuticals and biotechnology companies in the region.
Australian 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The Australian 3D cell culture market is expected to witness a significant growth with the CAGR of approximately 15% during the forecast period. 3D cell culture is one of the new evolving fields of research and technology in the market. With this technology, a 3D environment is provided that is used for the growth of cells in all directions.
China 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The China 3D cell culture market is expected to witness a significant growth with the CAGR of 17% during the forecast period. The market in China has both medium and long-term potential due to its large market size, an aging population, fluctuating disease profile and rapidly improving life. Furthermore, the Chinese economy is becoming an R&D-intensive economy on all fronts, which is the major factor for the growth of the life science industry of China.
European 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The European 3D cell culture market is expected to witness a significant growth with the CAGR of 14.7% during the forecast period. Europe registers a significant share in the overall 3D cell culture market across the globe. Europe has made significant R&D in biotechnology mainly focused by a shift towards the use of live model systems for drug discovery and evaluation, use of animal-derived component-free media and reagents, and growing demand for advanced biologics and bio-similar produced by biopharmaceutical manufacturers, thereby promoting the growth of the technologies such as 3D cell culture.
Germany 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The Germany 3D cell culture market is expected to witness a significant growth with the CAGR of 15% during the forecast period. Germany is the global leading medical biotech nation behind the US which makes it a prospering market for the 3D cell culture. The presence of long-established and start-up companies are the other major factor driving the growth for the 3D cell culture market in the region.
Indian 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The Indian 3D cell culture market is expected to witness a significant growth with the CAGR of 21% during the forecast period. India is one of the fastest growing 3D cell culture markets in the Asia-Pacific region. The Indian pharmaceutical industry has been consistently growing at a significant rate over the last five years which makes India a potential market for the cell culture technologies.
North American 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The North American 3D cell culture market is expected to witness a significant growth with the CAGR of 13.3% during the forecast period. The North American market for 3D cell culture is a significant market and is analyzed on the basis of the country such as the US and Canada. The factors that are contributing significantly to market growth include R&D, and high healthcare expenditure.
UK 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The UK 3D cell culture market is expected to witness a significant growth with the CAGR of 16% during the forecast period. UK has made significant R&D in biotechnology mainly focused by a shift towards the use of live model systems for drug discovery and evaluation, use of animal-derived component-free media and reagents, and growing demand for advanced biologics and bio-similar produced by biopharmaceutical manufacturers, thereby promoting the growth of the technologies such as 3D cell culture.
US 3D Cell Culture Market Size, Share & Trends Analysis Report, By Product Type (Scaffold-Based 3D Cell Culture, Hydrogels/Ecm Analogs, Solid Scaffolds, Micropatterned Surfaces, Scaffold-Free 3D Cell Culture, Low-Adhesion Microplates, Hanging Drop Plates, 3D Bioreactors, 3D Petri Dishes), By Application (Cancer And Stem Cell Research, Drug Discovery, Toxicology, and Tissue Engineering & Regenerative Medicine), and Forecast, 2019-2025
Published: Feb 2026
The US 3D cell culture market is expected to witness a significant growth with the CAGR of 13.3% during the forecast period. The US market is dominating due to factors such as investments in R&D, high healthcare expenditure, the presence of key players and the rising prevalence of cancer patients.
Asia-Pacific Diagnostic Biomarker Market Size, Share & Trends Analysis Report by Diagnostic Technique (ELISA, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay, and Others), By Application (Oncology, Cardiology, Neurology, Nephrology, and Others), and Forecast 2019-2025
Published: Feb 2026
The
Asia-Pacific diagnostic biomarker market is estimated to grow significantly at
a CAGR of around 14% during the forecast period. Asia-Pacific is both a strong
and promising market for diagnostic biomarkers. This is particularly due to the
strong population base, high prevalence of chronic diseases such as cancer and
CVDs in Asian countries such as China, Japan, and India.
China Diagnostic Biomarker Market Size, Share & Trends Analysis Report by Diagnostic Technique (ELISA, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay, and Others), By Application (Oncology, Cardiology, Neurology, Nephrology, and Others), and Forecast 2019-2025
Published: Feb 2026
The
diagnostic biomarker market in China is estimated to grow significantly at a
CAGR of over 13% during the forecast period. China is expected to generate a
significant market for diagnostic biomarkers during the forecast period. China
has emerged as a strong player in the biotechnology sector that results from
the huge investments in R&D by the Chinese government.
European Diagnostic Biomarker Market Size, Share & Trends Analysis Report by Diagnostic Technique (ELISA, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay, and Others), By Application (Oncology, Cardiology, Neurology, Nephrology, and Others), and Forecast 2019-2025
Published: Feb 2026
The
European diagnostic biomarker market is estimated to grow significantly at a
CAGR of more than 11% during the forecast period. Factors that are contributing
significantly in the market growth include the presence of a well-developed
healthcare sector and considerably high healthcare expenditure and
infrastructure in its economies such as Germany, UK, France and many more.
Germany Diagnostic Biomarker Market Size, Share & Trends Analysis Report by Diagnostic Technique (ELISA, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay, and Others), By Application (Oncology, Cardiology, Neurology, Nephrology, and Others), and Forecast 2019-2025
Published: Feb 2026
German
diagnostic biomarker market is estimated to grow significantly at a CAGR of
over 12% during the forecast period. It is due to the increasing geriatric
population, the presence of highly specialized urologists for cancer treatment
and bit low-cost treatment as compared to UK, which is attracting medical
tourism in the country.
North American Diagnostic Biomarker Market Size, Share & Trends Analysis Report by Diagnostic Technique (ELISA, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay, and Others), By Application (Oncology, Cardiology, Neurology, Nephrology, and Others), and Forecast 2019-2025
Published: Feb 2026
The
North American diagnostic biomarker market is estimated to grow significantly
at a CAGR of over 13% during the forecast period. Factors that are contributing
significantly in the market growth include the presence of well-developed
healthcare infrastructure, increasing healthcare R&D investments, high
healthcare expenditure and others.
UK Diagnostic Biomarker Market Size, Share & Trends Analysis Report by Diagnostic Technique (ELISA, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay, and Others), By Application (Oncology, Cardiology, Neurology, Nephrology, and Others), and Forecast 2019-2025
Published: Feb 2026
The
UK diagnostic biomarker market is estimated to grow significantly at a CAGR of
more than 12% during the forecast period. The major factor that is driving the
market includes a high prevalence of cancer and chronic diseases in the region.
US Diagnostic Biomarker Market Size, Share & Trends Analysis Report by Diagnostic Technique (ELISA, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay, and Others), By Application (Oncology, Cardiology, Neurology, Nephrology, and Others), and Forecast 2019-2025
Published: Feb 2026
The
US diagnostic biomarker market is estimated to grow significantly at a CAGR of
more than 12% during the forecast period. Factors that are contributing
significantly in the market growth include the presence of well-developed
healthcare infrastructure, increasing healthcare R&D investments, high
healthcare expenditure and others.
Asia-Pacific Genomic Biomarker Market Size, Share & Trends Analysis Report, By Application (Oncology, Cardiology, Neurology, and Others), By End-User (Hospitals and Diagnostic & Research Laboratories), and Forecast 2019-2025
Published: Feb 2026
The
Asia-Pacific genomic biomarker market is estimated to grow significantly at a
CAGR of over 16% during the forecast period. Asia-Pacific is both a strong and
promising market for genomic biomarkers market. This is particularly due to the
strong population base, high prevalence of chronic diseases such as cancer and
CVDs in Asian countries such as China, Japan, and India.
China Genomic Biomarker Market Size, Share & Trends Analysis Report, By Application (Oncology, Cardiology, Neurology, and Others), By End-User (Hospitals and Diagnostic & Research Laboratories), and Forecast 2019-2025
Published: Feb 2026
The
genomic biomarker market in China is estimated to grow significantly at a CAGR
of over 17% during the forecast period. China has emerged as a strong player in
the biotechnology sector that results from the huge investments in R&D by
the Chinese government. Chinese life science sector has progressively grown in
the last years as a result of strong R&D and funding.
European Genomic Biomarker Market Size, Share & Trends Analysis Report, By Application (Oncology, Cardiology, Neurology, and Others), By End-User (Hospitals and Diagnostic & Research Laboratories), and Forecast 2019-2025
Published: Feb 2026
The
European genomics biomarker market is estimated to grow significantly at a CAGR
of more than 14% during the forecast period. Factors that are contributing
significantly to the market growth include the presence of a well-developed
healthcare sector and considerably high healthcare expenditure and
infrastructure in its economies such as Germany, UK, France, and others.
Germany Genomic Biomarker Market Size, Share & Trends Analysis Report, By Application (Oncology, Cardiology, Neurology, and Others), By End-User (Hospitals and Diagnostic & Research Laboratories), and Forecast 2019-2025
Published: Feb 2026
The
Germany genomic biomarker market is estimated to grow significantly at a CAGR
of 15.6% during the forecast period. It is due to the increasing geriatric
population, the presence of highly specialized urologists for cancer treatment
and bit low-cost treatment as compared to UK, which is attracting medical tourism
in the country.
North American Genomic Biomarker Market Size, Share & Trends Analysis Report, By Application (Oncology, Cardiology, Neurology, and Others), By End-User (Hospitals and Diagnostic & Research Laboratories), and Forecast 2019-2025
Published: Feb 2026
The
North American genomic biomarker market is estimated to grow significantly at a
CAGR of over 15% during the forecast period. Factors that are contributing
significantly in the market growth include the presence of well-developed
healthcare infrastructure, increasing healthcare R&D investments, high
healthcare expenditure and others.
UK Genomic Biomarker Market Size, Share & Trends Analysis Report, By Application (Oncology, Cardiology, Neurology, and Others), By End-User (Hospitals and Diagnostic & Research Laboratories), and Forecast 2019-2025
Published: Feb 2026
The
UK genomic biomarker market is estimated to grow significantly at a CAGR of
more than 15% during the forecast period. The major factors driving market
growth include a high prevalence of cancer and chronic diseases in the region.
US Genomic Biomarker Market Size, Share & Trends Analysis Report, By Application (Oncology, Cardiology, Neurology, and Others), By End-User (Hospitals and Diagnostic & Research Laboratories), and Forecast 2019-2025
Published: Feb 2026
The
US genomic biomarker market is estimated to grow significantly at a CAGR of
around 15.6% during the forecast period. Factors that are contributing
significantly to the market growth include the presence of well-developed
healthcare infrastructure, increasing healthcare R&D investments, high
healthcare expenditure and others.
US CRISPR in Agriculture Market Size, Share & Trends Analysis Report by End-User (Academic & Research Institutes, and Biotech Companies), by Target Type (Crops, Livestock, and Aquaculture Driving and Sports) Forecast Period 2019-2025
Published: Feb 2026
The US CRISPR in agriculture market is expected to grow at a CAGR of 26.1% during the forecast period. The US is the leading market for CRISPR in agriculture in North America and the largest economy across the globe. The US is one of the leading countries in planting genetically modified crops, accounting for more than 40% of acres growing genetically modified crops across the globe.
UK CRISPR in Agriculture Market Size, Share & Trends Analysis Report by End-User (Academic & Research Institutes, and Biotech Companies), by Target Type (Crops, Livestock, and Aquaculture Driving and Sports) Forecast Period 2019-2025
Published: Feb 2026
CRISPR in agriculture in the UK market is expected to grow at a significant CAGR of 26.3% during the forecast period. Growing population in UK surge the demand for food across the nation. Editing plant genomes to feed a growing population is innovative technology in the agriculture industry. The potential of gene editing to address the growing demand for food has contributed to the growth of CRISPR in the agriculture market in UK.
North American CRISPR in Agriculture Market Size, Share & Trends Analysis Report by End-User (Academic & Research Institutes, and Biotech Companies), by Target Type (Crops, Livestock, and Aquaculture Driving and Sports) Forecast Period 2019-2025
Published: Feb 2026
North America is anticipated to be a major contributor to the growth of the CRISPR in agriculture market growing at a CAGR of 25.9%. North America is one of the strongest economies across the globe, comprising of around 23.3% of the world economy as per International Monetary Fund in 2017.
Japan CRISPR in Agriculture Market Size, Share & Trends Analysis Report by End-User (Academic & Research Institutes, and Biotech Companies), by Target Type (Crops, Livestock, and Aquaculture Driving and Sports) Forecast Period 2019-2025
Published: Feb 2026
Japan CRISPR in agriculture market is expected to grow at a significant CAGR of 23.0% during the forecast period. Japan’s agriculture, farming, and fishing are among the sectors of Japan’s economy and altogether account for 1.3% as of 2017-2018. The factor that primarily contributes to the market growth in Japan is the shortage of suitable land for cultivation.
India CRISPR in Agriculture Market Size, Share & Trends Analysis Report by End-User (Academic & Research Institutes, and Biotech Companies), by Target Type (Crops, Livestock, and Aquaculture Driving and Sports) Forecast Period 2019-2025
Published: Feb 2026
Indian CRISPR in agriculture market is expected to grow at a significant CAGR of 22.5% during the forecast period. India has the huge population, and some limitations in terms of availability of human resources, land and water for sustained agriculture for long-term security.
Europe CRISPR in Agriculture Market Size, Share & Trends Analysis Report by End-User (Academic & Research Institutes, and Biotech Companies), by Target Type (Crops, Livestock, and Aquaculture Driving and Sports) Forecast Period 2019-2025
Published: Feb 2026
European CRISPR in agriculture market is expected to grow at a significant CAGR of 25.6% during the forecast period. Europe is the well-established region that comprises few of the largest economies across the globe. The region has established agriculture research facilities in order to develop effective and productive crops. Additionally, due to increasing dependency on non-vegetarian foods such as meat, chicken, pork, and others.
Asia-Pacific CRISPR in Agriculture Market Size, Share & Trends Analysis Report by End-User (Academic & Research Institutes, and Biotech Companies), by Target Type (Crops, Livestock, and Aquaculture Driving and Sports) Forecast Period 2019-2025
Published: Feb 2026
Asia Pacific CRISPR in agriculture market is projected to grow at a significant CAGR of 23.6% during the forecast period. The growth of the region is attributed to the continuous R&D activities being implemented in the emerging economies of Asia-Pacific including India and China. The region has well-known agriculture research facilities for the development of effective and productive crops.
Global Wound Care Biologics Market Size, Share & Trends Analysis Report, By Product (Skin Substitute and Topical Agent), By Wound Type (Ulcers, Surgical and Traumatic Wounds, and Burns), By End-Use (Hospitals and Clinics, Burn Center, and Homecare) and Forecast 2019-2025
Published: Feb 2026
The global wound care biologics market is estimated to grow at a CAGR of 8.2% during the forecast period. Biologic wound healing therapies are intended to facilitate the re-establishment of the natural repair mechanisms. Moreover, wound care biologics may also involve the application of active biological agents, such as plant-derived active biomolecules which exhibit antioxidant, antimicrobial, or anti-inflammatory attributes.
US Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type (Creatine kinase (CK-MB), Troponins(T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others), By Application (Myocardial infraction, Congestive Heart Failure, Acute coronary syndrome, Atherosclerosis, and Others), By Location of Testing(Laboratory testing and Point of care testing) and Forecast 2019-2025
Published: Feb 2026
The US cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.2% during the forecast period. The major factors that propel the market growth include the high prevalnece of CVDs and heart related diseases in the country coupled with robust healthcare healthcare expenditure.
UK Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type (Creatine kinase (CK-MB), Troponins(T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others), By Application (Myocardial infraction, Congestive Heart Failure, Acute coronary syndrome, Atherosclerosis, and Others), By Location of Testing(Laboratory testing and Point of care testing) and Forecast 2019-2025
Published: Feb 2026
UK cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.7% during the forecast period. The major factor that contribute in the market growth include increasing CVDs in the country coupled with availability of advanced diagnostic technology for heart related diseases in the country.
North American Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type (Creatine kinase (CK-MB), Troponins(T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others), By Application (Myocardial infraction, Congestive Heart Failure, Acute coronary syndrome, Atherosclerosis, and Others), By Location of Testing(Laboratory testing and Point of care testing) and Forecast 2019-2025
Published: Feb 2026
The North American cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.1% during the forecast period. Increasing prevalence of CVDs in The US and Canada, Technological advancement in the cardiac biomarker, and robust healthcare expenditure and R&D in the region is the major fators that contribute to the market growth.
Germany Cardiac biomarker Market Size, Share & Trends Analysis Report by Type (Creatine kinase (CK-MB), Troponins(T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others), By Application (Myocardial infraction, Congestive Heart Failure, Acute coronary syndrome, Atherosclerosis, and Others), By Location of Testing(Laboratory testing and Point of care testing) and Forecast 2019-2025
Published: Feb 2026
Germany's cardiac biomarker market is estimated to grow significantly
at a CAGR of around 7.5% during the forecast period. The market mainly is driven
due to due to the massive population of CVD, CHD &stroke and rise in the adoption of a cardiac biomarker for the diagnosis of CVD and other heart-related diseases.
France Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type (Creatine kinase (CK-MB), Troponins(T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others), By Application (Myocardial infraction, Congestive Heart Failure, Acute coronary syndrome, Atherosclerosis, and Others), By Location of Testing(Laboratory testing and Point of care testing) and Forecast 2019-2025
Published: Feb 2026
France cardiac biomarker market is estimated to grow significantly
at a CAGR of around 6.6% during the forecast period. The rising incidences of
CVD result in the diagnosis rate propelling the cardiac biomarker market.
European Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type (Creatine kinase (CK-MB), Troponins(T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others), By Application (Myocardial infraction, Congestive Heart Failure, Acute coronary syndrome, Atherosclerosis, and Others), By Location of Testing(Laboratory testing and Point of care testing) and Forecast 2019-2025
Published: Feb 2026
The European cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.1% during the forecast period. The cardiac biomarker market has a significant scope in the European region due to growing heart related diseases such as CVD, CHD, and stroke.
Asia-Pacific Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type (Creatine kinase (CK-MB), Troponins(T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others), By Application (Myocardial infraction, Congestive Heart Failure, Acute coronary syndrome, Atherosclerosis, and Others), By Location of Testing(Laboratory testing and Point of care testing) and Forecast 2019-2025
Published: Feb 2026
Asia-Pacific cardiac biomarker market is estimated to grow significantly
at a CAGR of around 7.1% during the forecast period. The Asia-Pacific has a potential
market in cardiac biomarkers due to various factors such as rising healthcare
spending, improving infrastructure& economy, and rising standards of
living.
Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report by technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software) By Application (Clinical Application, Research Application, and Forensic Application), Forecast Period 2019-2025
Published: Feb 2026
The digital PCR and real-time PCR is anticipated to grow at a CAGR of 8.0% during the forecast period. The Polymerase Chain Reaction (PCR) is a technique that is performed in the laboratory to amplify DNA and developing many copies of DNA in interest.
Male Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Semen Analysis, Urinalysis, Genetic Testing, Testicular Biopsy, Hormonal Tests and Others) By Treatment (Drugs, ART Therapy and Surgery) and Forecast, 2019-2025
Published: Feb 2026
The global male infertility diagnosis
and treatment market is growing at a CAGR of more than 4% during the forecast period. Infertility
in men occurs due to deficiency in sperm formation. Infertility can have
several causes and may rely on genetics, fitness, diseases, general health and
dietary contaminants.
Indian Infertility Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report, By Diagnosis (Male Infertility {Semen Analysis, Genetic Testing, Testicular Biopsy, Hormonal Tests and Others} Female Infertility {Ovulation Testing, Hysterosalpingography, Imaging Tests, Ovarian Reserve Testing, Hormone Testing and Others), By Treatment and Forecast, 2019-2025
Published: Feb 2026
Indian infertility diagnosis
and therapeutics market has witnessed CAGR of 5.8% owing to a significant
prevalence of infertility and the government financial incentives for treatment
of infertility. For instance, according to the World Health Organization (WHO)
estimate, the overall prevalence of primary infertility in India ranges between
3.9% to 16.8%.
Polymerase Chain Reaction (PCR) Market Size, Share & Trends Analysis Report by Application (Dermatology, Ophthalmology, Dentistry, Oncology, Wound Healing, and Others), by Product (Instruments, Reagents and Consumables, and Software) and by End-User (Pharmaceutical and Biotechnology Industries, Clinical Diagnostics Labs and Hospitals, and Academic and Research Organizations) Forecast Period (2024-2031)
Published: Feb 2026
Polymerase chain reaction (PCR) market is anticipated to grow at a significant CAGR of 4.3% during the forecast period (2024-2031). The demand for PCR-based diagnostics is rising due to the prevalence of infectious diseases and emerging pathogens. Innovations such as real-time and digital PCR are making these tests more accessible, even in remote areas. Personalized medicine benefits from PCR's genetic analysis capabilities, while investments from pharmaceutical and biotech companies, government support, and early diagnosis awareness drive market growth. The integration with other technologies and automation of PCR systems additionally bolsters industry growth. Nonetheless, high costs, regulatory complexities, the need for skilled professionals, and competition from new diagnostic technologies like CRISPR-based assays and isothermal amplification methods present significant challenges to the global PCR market.
Protein Stability Analysis Market Size, Share & Trends Analysis Report, By Technique (Spectroscopy, Chromatography, Differential Scanning Calorimetry, Differential Scanning Fluorimetry, Surface Plasmon Resonance and Other Techniques), By Product (Instruments, Accessories and Consumables and Software), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) and Research Institutes) and Forecast 2019-2025
Published: Feb 2026
The global protein stability analysis market is estimated to grow at a CAGR of 8.4% during the forecast period. The major factors encouraging the growth of the market include the significant rise in pharmaceutical R&D programs and the emerging role of bioinformatics software in life science researches.
Organ Preservation Market Size, Share & Trends Analysis Report By Technique (Static Cold Storage (SCS) Technique, and Dynamic Cold Storage (DCS) Technique), and by Organ Type (Kidney, Liver, Lung, Heart, and Others), Forecast Period (2026-2035)
Published: Apr 2026
organ preservation market was valued at $342.3 million in 2025 and is projected to reach $622.1 million by 2035, growing at a CAGR of 6.2% from 2026 to 2035. The global market is experiencing steady expansion, supported by a combination of technological advancements and increasing procedural adoption across healthcare systems. Continuous innovation in preservation methodologies has improved clinical reliability and extended viable usage timelines, contributing to broader acceptance. Additionally, the growing emphasis on optimizing outcomes and reducing operational inefficiencies has encouraged the uptake of advanced solutions. Market participants are also benefiting from incremental improvements in product design and performance, which enhance usability and consistency. Furthermore, rising awareness among healthcare providers regarding improved preservation techniques is reinforcing demand. Collectively, these factors are contributing to sustained and measurable market growth.
CRISPR Technology Market Size, Share & Trends Analysis Report, By Application (Biomedical Applications, Agricultural Applications, and Industrial Applications), By End-User (Pharmaceutical & Biopharmaceutical Companies and Academic & Research Institutes), and Forecast 2019-2025
Published: Feb 2026
The global CRISPR technology market is expected to witness a growth rate of 27.1% during the forecast period. The market growth is attributed to increasing government and private funding and rising demand for CRISPR coupled with advancement in technology. Further, the players operating in the market are contributing a significant share to enhance the CRISPR technology market size.
Global Cancer/Tumor Profiling Market Size, Share & Trends Analysis Report by Technology (Immunoassays, In Situ Hybridization, Sequencing Techniques, Mass Spectrometry, and Others), by Cancer Type (Lung Cancer, Breast Cancer, Prostate Cancer, Melanoma Cancer, and Others), and by End-User (Clinics and Hospitals, and Research Centers) and Forecast 2019-2025
Published: Feb 2026
Global cancer/tumor profiling market is anticipated
to grow at a CAGR of 8%, during the forecast period. Cancer/tumor profiling
offers much-needed information about the genes that cause cancer, which in
turn, provides insights regarding the mechanism of cancer.The rising number of
research projects on oncology due to the increasing prevalence of oncological
disorders across the globe is one of the major factors driving the growth of
the market.
Bioelectronics Market Size, Share & Trends Analysis Report by Product Type (Bioelectronic Devices, Bioelectronic Medicine, Biosensors, Biochips & Lab-on-a-Chip Systems, and Neural Interfaces & Neuroprosthetics) By Device Type (Implantable Devices, Wearable Bioelectronics, External Devices, and Point-of-Care Devices) and by End-User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Homecare & Individual Users) Forecast Period, (2026-2035)
Published: Apr 2026
Bioelectronics market valued at $18,236.8 million in 2025 and is projected to reach $52,805.1 million by 2035, growing at a CAGR of 11.3% during the forecast period (2026-2035). The global bioelectronics market is gaining strong momentum as healthcare systems increasingly integrate electronic technologies with biological processes to enable advanced diagnosis, monitoring, and therapeutic interventions. Growth is being driven by rising demand for minimally invasive treatments, continuous health monitoring, and precision medicine approaches. Innovations in implantable devices, neural interfaces, and bioelectronic medicines are enhancing the ability to modulate physiological functions in real time. Additionally, the convergence of electronics, biotechnology, and data analytics is enabling more personalized and efficient treatment pathways. As regulatory frameworks evolve to support advanced medical technologies, bioelectronics is emerging as a critical pillar in next-generation healthcare delivery.
Liquid Handling System Market Size, Share & Trends Analysis Report by Instruments (Automated Pipetting System, Manual Pipettes, Pipette Tips, Dispensers, Burettes and Others), by Type (Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling), by Application (Serial Dilution, Titration, Polymerized Chain Reaction (PCR), Protein Crystallization, Next Generation Sequencing, and Others), Forecast Period (2026-2035)
Published: Apr 2026
liquid handling system market was valued at $4.8 billion in 2025 and is projected to reach $10.5 billion by 2035, growing at a CAGR of 8.1% from 2026 to 2035. The global liquid handling systems market is experiencing steady expansion driven by the increasing integration of automation within laboratory workflows to enhance precision and efficiency. Growing reliance on high-throughput experimental processes in life sciences and pharmaceutical research is further contributing to sustained demand. Additionally, the rising complexity of analytical procedures has reinforced the need for accurate and reproducible liquid handling solutions. Continuous advancements in instrumentation design and user-friendly interfaces are also supporting broader adoption across research and clinical settings. Moreover, the consistent utilization of consumables associated with these systems ensures recurring revenue streams within the market. Collectively, these factors are reinforcing a stable growth trajectory over the forecast period.
Pharmaceutical Filtration Market Size, Share & Trends Analysis Report by Technique (Microfiltration, Ultrafiltration, Nanofiltration, and Others), by Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, and Air Purification) Forecast Period, (2026-2035)
Published: Apr 2026
Pharmaceutical filtration market valued at $22,265.1 million in 2025 and is projected to reach $44,639.4 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global pharmaceutical filtration market is progressing steadily as biopharmaceutical and pharmaceutical manufacturers intensify their focus on contamination control, product purity, and regulatory compliance across production processes. Growth is being supported by the rising demand for biologics, vaccines, and sterile injectable drugs, which require highly efficient filtration systems to ensure product safety and consistency. Increasing adoption of advanced membrane technologies, single-use filtration systems, and automated filtration solutions is further enhancing process efficiency and scalability. Additionally, the growing complexity of drug formulations and stringent quality standards are reinforcing the need for high-performance filtration solutions across upstream and downstream processing stages.
Synthetic Biology Market Size, Share & Trends Analysis Report by Deployment (Enabling Product, Core Product and Enabled Product), by Technology (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics and Others), and by Application (Medical Application, Industrial Application, Food &, Agriculture, and Environmental Application) Forecast Period, (2026-2035)
Published: Apr 2026
Synthetic biology market valued at $16,502.6 million in 2025 and is projected to reach $74,176.2 million by 2035, growing at a CAGR of 16.3% during the forecast period (2026-2035). The global synthetic biology market is advancing as biotechnology firms, pharmaceutical companies, and research institutions intensify their focus on engineering-driven biological innovation and programmable biological systems. Growth is being reinforced by the expanding adoption of gene editing technologies such as CRISPR-Cas9, automated DNA synthesis, and biofoundry platforms that accelerate design-build-test cycles. Demand is further supported by the increasing need for sustainable bio-based production solutions across healthcare, agriculture, and industrial sectors. As regulatory bodies emphasize safe and standardized development of engineered organisms, synthetic biology platforms are becoming essential for improving efficiency, scalability, and reproducibility in biological research and manufacturing.
Tissue Banking Market Size, Share & Trends Analysis Report, By Products (Equipment and Consumables & Media) By Applications (Medical Research, Therapeutics, and Others), Forecast Period (2026-2035)
Published: Apr 2026
tissue banking market was valued at $3.1 billion in 2025 and is projected to reach $6.2 billion by 2035, growing at a CAGR of 7.2% from 2026 to 2035. The expansion of this market is being supported by increasing demand for advanced preservation techniques and reliable storage systems across clinical and research settings. Growing emphasis on maintaining biological sample integrity for extended durations has led to higher adoption of specialized equipment and preservation media. In addition, continuous improvements in cryogenic technologies and standardized handling protocols are enhancing operational efficiency and consistency. The rising volume of biomedical research activities, particularly in regenerative medicine and translational studies, is further contributing to sustained product demand. Furthermore, regulatory focus on quality assurance and traceability is encouraging institutions to invest in validated and compliant solutions. Collectively, these factors are reinforcing steady growth in the market.
Global Surgical Instrument Tracking System Market Size, Share & Trends Analysis Report by Technology (Bar Code Scanning and Radio-Frequency Identification (RFID)), by Component (Software, Hardware, Services), by Vertical (Hospitals and Ambulatory Surgical Centers) and Forecast 2019-2025
Published: Feb 2026
The global surgical instrument tracking system market is anticipated to grow at the CAGR of 14%, during the forecast period. There are various key factors that are contributing to the growth of the global surgical instrument tracking system market such as increasing incidence of retained surgical instrument cases, which possesses a need for surgical instrument inventory management.
Global Cell Culture Market Size, Share & Trends Analysis Report by Product (Equipment and Consumables), By Application (Biopharmaceuticals Application, Diagnostics, Drug Discovery & Development, Tissue Engineering & Regenerative Medicine, Cancer & Stem Cell Research, and Others), By End-User (Pharmaceutical & Biotechnology Companies and Research Institutes), and Forecast 2019-2025
Published: Feb 2026
The global cell
culture market is projected to grow at a significant CAGR of 15.3% during the
forecast period. The market is mainly driven by the high application of cell
culture systems used in the drug discovery and tissue engineering.
Global Optogenetics Actuators and Sensors Market Size, Share & Trends Analysis Report, by Product Type (Actuators, Sensors), by Disease Type (Retinal Disorders, Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Autism, and Others) and Forecast, 2019-2025
Published: Feb 2026
Optogenetics
actuators & sensors market is growing significantly and is considered as a recent
development in neuroscience that allows the use of optically activated proteins
to control neuronal functions. Optogenetics helps in the treatment of various
diseases such as Parkinson’s disease, Alzheimer’s diseases, retinal disorders,
autism and others.
Cell Expansion Market by Cell Type (Human Cells and Animal Cells), by Product (Bioreactors, Automated Cell Expansion System, Reagents, Consumables, and Others), by Application (Cancer Research and Regeneration Medicines), by End-Users - Industry Size, Share, Global Trends, Competitive Analysis and Forecast, 2019 to 2025
Published: Feb 2026
Global cell expansion market is anticipated to exhibit a considerable growth rate during the forecast period. The process of cell expansion is being used for several applications, which includes microlevel research of cells, screening of drugs, therapeutic development, and so on.
Gene Synthesis Market by Method (Oligonucleotide Synthesis and Gene Assembly), by End-User (Biopharmaceutical Companies, Contract Research Organization (CROs) and Academic and Research Institutes) - Global Industry Share, Growth, Competitive Analysis and Forecast, 2019-2025
Published: Feb 2026
Gene synthesis could be defined as a flexible and powerful molecule engineering tool employed in synthetic biology which is mainly used for chemical DNA synthesis. Starting from the first artificial gene synthesis by Gobind Khorana's group in 1970, frequent developments and updates have been seen in the synthesis such as sequencing, automation, and amplification.
Cell Signaling Market by Type (Paracrine Signaling, Endocrine Signaling, Autocrine Signaling, and Others), by Technology (Western Blotting, Immunohistochemistry, Elisa Solutions, Flow Cytometry, and Others), by Application (Research and Medical) - Global Industry Share, Growth, Competitive Analysis and Forecast, 2019-2025
Published: Feb 2026
Cell signaling market is expected to grow at a moderate rate during the forecast period 2019-2025. Cell signaling is the communication process between different groups of cells and tissues that governs basic cellular activities and coordinates all cell actions. It is a major field in modern medical practice and diagnosis.
Next Generation Cancer Diagnostics Market by Technology (Next Generation Sequencing, QPCR and Multiplexing, Protein Microarrays, DNA Microarrays, and Others), by Application (Biomarker Development, Proteomic Analysis, Cancer Screening, and Others) by End-User (Hospital, Clinics and Research Centers) – Global Trends, Industry Size, Share, Growth, and Forecast, 2025-2035
Published: Feb 2026
Next generation cancer diagnostics market is expected
to grow at a significant rate during the forecast period
2019-2025. Next-generation sequencing is used as a cancer diagnostic
tool for analyzing genome sequences in cancer. The technique uses
several technologies for diagnosis of cancer, including protein
microarrays, DNA microarrays, next-generation sequencing, and
lab-on-a-chip & reverse transcriptase-PCR (RT-PCR), among others.
Protein Crystallization Market Size, Share & Trends Analysis Report by Product Type (Instruments, Consumables & Reagents and Software & Services), By Technology (X-Ray Crystallography, Electrophoresis, Spectroscopy, and Chromatography), and By End-User (Biotechnology & Pharmaceuticals Companies and Research Institutes) Forecast Period, (2026-2035)
Published: Feb 2026
Protein crystallization market was valued at $1,833.5 million in 2025 and is projected to reach $3,415.3 million by 2035, growing at a CAGR of 6.5% during the forecast period (2026-2035). The global protein crystallization market is expanding as research teams intensify efforts to understand protein structures with greater precision. Laboratories are adopting more advanced crystallization tools to support drug-target validation, structural modeling, and the study of complex biomolecules. Growth in biologics and targeted therapies has further increased the need for reliable crystallization methods that can guide early-stage discovery. Many organizations are upgrading to newer systems that streamline screening and improve experimental consistency. At the same time, demand for high-quality reagents and specialized kits continues to rise as projects become more technically demanding.
Bioreactor Market Size, Share & Trends Analysis Report by Material (Stainless Steel, and Single-use), By Production (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), By End-User (Biopharmaceutical Companies and Contract Research Organizations (CRO)), Forecast Period (2026-2035)
Published: Feb 2026
Bioreactor market was valued at $10,841.4 million in 2025 and is projected to reach $35,887.7 million by 2035, growing at a CAGR of 11.6% during the forecast period (2026-2035). The global bioreactor market is witnessing steady expansion, driven by continuous advancements in bioprocessing technologies and rising demand for biologics. Increasing focus on efficient cell culture production has encouraged the adoption of modern reactor systems with enhanced process control. Growing research in therapeutic proteins, monoclonal antibodies, and vaccines is further stimulating market growth. The integration of automation and digital monitoring tools has improved productivity and reduced operational risks. Biomanufacturers are prioritizing scalable and flexible solutions to meet evolving production needs.
Lateral Flow Assays Market Size, Share & Trends Analysis By Product (Kits & Reagents, Lateral Flow Readers, and Mobile Readers), By Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assay), By Application (Clinical testing, Veterinary Diagnostics), By End-User (Hospitals and Diagnostic Centres, Home Care, Pharmaceuticals and Biotechnology Companies) Forecast Period, (2026-2035)
Published: Mar 2026
Lateral flow assays market is expected to reach approximately $15.7 billion by 2035, growing at a CAGR of 7.0% from 2026 to 2035, up from $8.1 billion in 2025. The global lateral flow assays market is experiencing steady growth driven by the increasing reliance on rapid diagnostic solutions across healthcare systems. Greater emphasis on early disease identification and timely clinical decision-making has strengthened the adoption of these assays in routine medical practice. Advances in assay design have improved analytical reliability, supporting their use beyond preliminary screening applications. In addition, expanding diagnostic access in outpatient and decentralized settings has reinforced demand for compact and efficient testing formats. The rising need for cost-effective diagnostic tools has further supported commercial uptake in both developed and emerging markets.
Laboratory Centrifuge Market Size, Share & Trends Analysis Report by Product Type (Devices, Microcentrifuge, Multipurpose Centrifuge, Floor-Based Centrifuge, Ultracentrifuge, and Accessories) by Application (Diagnostic, Microbiology, Genomics, Proteomics, Blood Component Separation, Others) and By End-User (Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies) Forecast Period (2025-2035)
Published: Feb 2026
Laboratory centrifuge market was valued at $2.1 billion in 2024 and is projected to reach $3.7 billion by 2035, growing at a CAGR of 5.4% during the forecast Period (2025-2035). The market growth is driven by factors such as the increasing prevalence of chronic and infectious diseases, rising R&D in the biotechnology and pharmaceutical sectors, and technological advancements like automation and energy-efficient models. Key drivers include a growing demand for medical research and diagnostics, government initiatives, and the expansion of cell and gene therapy manufacturing, which requires advanced separation and purification techniques.
Liquid Biopsy Market Size, Share & Trends Analysis by Biomarker Type (Circulating Tumor Cells, Circulating Tumor DNA, and Others), by Cancer Type (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers), and by End-User (Hospitals and Laboratories, and Academic and Research Centres), Forecast Period (2026-2035)
Published: Mar 2026
Liquid biopsy market was valued at $3.0 billion in 2025 and is projected to reach $12.1 billion by 2035, growing at a CAGR of 15% during the forecast Period (2026-2035). The Market growth is driven by the rising cancer burden, demand for non-invasive diagnostics, personalized medicine, and expanding applications beyond oncology (prenatal, infectious diseases). its key factors fueling this expansion include technological advancements, increased R&D funding, and the shift to real-time monitoring, although challenges like high costs, reimbursement issues, and variable sensitivity for early detection persist. North America currently leads the market, with Asia-Pacific emerging as a key growth region.
Genetic Testing Market Size, Share & Trends Analysis Report by technology (Polymerase Chain Reaction, DNA sequencing, Cytogenetics (Karyotyping and FISH), Microarrays, Gene Expression Profiling) By Type (Prenatal and New-Born Genetic Testing, Predictive Testing, Diagnostic Testing, Carrier Testing, and Other) By Diseases (Cancer, Alzheimer’s and Parkinson, Fanconi Anaemia, Sickle Cell Anaemia, Cardiovascular Diseases, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Genetic testing market was valued at $22.1 billion in 2025 and is projected to reach $44.0 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The global genetic testing market is experiencing steady growth, driven by increasing awareness of early disease detection and personalized medicine. Advances in technologies such as polymerase chain reaction, DNA sequencing, and microarray analysis have significantly improved accuracy and efficiency in genetic diagnostics. The rising prevalence of chronic and hereditary diseases, including cancer and cardiovascular disorders, has further increased demand for genetic testing services. Expanding applications in prenatal, newborn, predictive, and diagnostic testing are strengthening market adoption across healthcare systems. Supportive government initiatives and growing investments in genomics research are also contributing to market expansion. Additionally, continuous innovation and declining costs of genetic testing technologies are expected to sustain long-term market growth during the forecast period.
Microarray Market Size, Share & Trends Analysis by Type (DNA Microarrays, Protein Microarray, Peptide Microarray, Tissue Microarray, and Others), By Application (Diagnosis & Prognosis, Pharmacogenomics & Theragnostic, Drug Discovery, and Others), Forecast Period (2025-2035)
Published: Feb 2026
Microarray market was valued at $5.8 billion in 2024 and is projected to grow at a CAGR of 8.7% from 2025 to 2035. Microarrays are one of the powerful technologies for the analysis of gene expression that can be used for various experimental purposes. The developments of microarrays have enhanced the results of genetic testing. Microarrays are used in a variety of applications, including gene discovery, disease diagnosis, drug discovery, and toxicological research. The rising incidences of cancer are the major factor contributing to the growth of the market. Moreover, the increasing prevalence of various chronic diseases and the rise of the usage of microarray technology for the diagnosis of such infectious diseases are also contributing to the growth of the microarray market. The growing regulatory approvals to push clinical adoption of advanced diagnostic solutions are expected to drive the global microarray market during the forecast period.
Biopreservation Market Size, Share & Trends Analysis Report by Product (Equipment, Media and Solution), and by Application (Regenerative Medicine, Biobanking, and Drug Discovery) Forecast Period (2024-2031)
Published: Feb 2026
Biopreservation market is anticipated to grow at a significant CAGR of 15.2% during the forecast period (2024-2031). Biopreservation is a process that extends the life of biological products such as stem cells, DNA, tissues, and organs-outside of their normal habitat by preserving their integrity and functionality at varying temperatures. The growing biotechnology industry is a key contributor to the growth of the global market.
Bioprosthetic Heart Valves Market Size, Share & Trends Analysis by Product Type (Transcatheter Bioprosthetic Valves, Surgical Bioprosthetic Valves (Stented and Stentless), and Sutureless Bioprosthetic Valves), by Valve Position (Aortic Valve, Mitral Valve, Tricuspid Valve, and Pulmonary Valve), by Material Type (Bovine Tissue, Porcine Tissue, and Others), and by End Users (Hospitals, Cardiac Surgery Centers, Specialty Cardiac Clinics, and Ambulatory Surgical Centers Forecast Period (2026-2035)
Published: Apr 2026
bioprosthetic heart valves market was valued at $9.5 billion in 2025 and is projected to reach $25.1 billion by 2035, growing at a CAGR of 10.2% from 2026 to 2035. The global market is expanding as a result of the rising prevalence of cardiovascular conditions and the increasing preference for advanced treatment options that improve clinical outcomes. Technological progress in valve design and minimally invasive procedures has enhanced adoption across both developed and emerging healthcare systems. In addition, the growing elderly population, which is more susceptible to valvular disorders, continues to contribute to sustained demand. Improved access to specialized cardiac care and the gradual shift toward less invasive interventions are further supporting procedural volumes. Regulatory approvals and ongoing product innovation have also strengthened the availability of newer solutions in clinical practice. Collectively, these factors are contributing to steady market growth over the forecast period.
Genotyping Market Size, Share & Trends Analysis Report by Products (Kits, Reagents and Instruments), by Technology (Mass Spectrometry, Microarray, Sequencing, PCR, Electrophoresis, and Others) by Application (Drug Discovery, Personalized Medicine, Pharma Genomics, and Diagnostic Research) Forecast Period, (2026-2035)
Published: Apr 2026
Genotyping market valued at $16,203.5 million in 2025 and is projected to reach $46,917.6 million by 2035, growing at a CAGR of 11.3% during the forecast period (2026-2035). The global genotyping market is witnessing steady expansion as healthcare systems, research institutions, and biotechnology companies intensify their focus on precision medicine and population-scale genomic analysis. Growth is being supported by the increasing adoption of high-throughput genotyping platforms, next-generation sequencing technologies, and automated laboratory workflows that enhance data accuracy and processing efficiency. Rising demand for genetic variation analysis in disease research, pharmacogenomics, and agricultural biotechnology is further strengthening market momentum. As regulatory bodies emphasize evidence-based diagnostics and personalized treatment strategies, genotyping technologies are becoming essential tools for improving clinical outcomes and accelerating research timelines.
Amniotic Membrane Market Size, Share & Trends Analysis Report by Product Type (Cryopreserved Amniotic Membrane, Dehydrated Amniotic Membrane, and Lyophilized (Freeze-Dried) Amniotic Membrane), by Application (Ophthalmology, Wound Care, Orthopedics, Plastic & Reconstructive Surgery, and Others), by End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), and Research & Academic Institutes), Forecast Period (2026–2035)
Published: May 2026
Amniotic membrane market was valued at $1.5 billion in 2025 and is projected to reach $3.9 billion by 2035, growing at a CAGR of 10.2% during the forecast period (2026-2035). The market is expanding steadily, supported by the increasing adoption of regenerative treatment solutions across clinical settings. Rising incidence of chronic wounds and ophthalmic conditions is contributing to consistent product demand. Advancements in preservation and processing techniques have improved product reliability and usability. Healthcare providers are showing a stronger preference for biologically derived materials that enhance healing outcomes. In addition, ongoing investments in healthcare infrastructure and specialized care services are reinforcing overall market growth.
Downstream Processing Market Size, Share & Trends Analysis Report by Product Type (Chromatography Systems, Filters, Single-Use Systems, Centrifuges, Evaporators & Dryers, and Accessories & Consumables), by Technique (Solid-Liquid Separation, Purification, and Polishing), by Application (Monoclonal Antibodies, Vaccines, Insulin, Growth Hormones, Blood Plasma Products, Recombinant Proteins, and Cell & Gene Therapy Products), by End-User (Biopharmaceutical Companies, Contract Development & Manufacturing Organizations (CDMOs), and Academic & Research Institutes), Forecast Period (2026–2035)
Published: Apr 2026
Downstream Processing market was valued at $40.2 billion in 2025 and is projected to reach $124.7 billion by 2035, growing at a CAGR of 15.9% during the forecast period (2026-2035). The market is growing due to rising investment in biopharmaceutical manufacturing facilities and capacity expansion across key production regions. Increasing demand for monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies has strengthened the need for efficient downstream processing systems. Manufacturers are adopting modern purification, filtration, and single-use technologies to improve yield, product quality, and operational efficiency. Regulatory focus on process consistency and contamination control is encouraging upgrades to validated processing equipment. Continuous innovation in automation, membrane technologies, and chromatography platforms is further supporting market expansion.
Bio-Imaging Technology Market Size, Share & Trends Analysis Report by Technology Type (Medical Bio-Imaging, and Molecular Bio-Imaging) by Modality (X-ray, CT, MRI, Ultrasound, Nuclear Imaging, and Optical Imaging) by End User (Hospitals & Clinics, Diagnostic Imaging Centers, Academic & Research Institutes, and Pharmaceutical & Biotechnology Companies) Forecast Period, (2026-2035)
Published: Apr 2026
Bio-Imaging technology market valued at $65.9 million in 2025 and is projected to reach $119.9 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The global bio-imaging technology market is progressing steadily as healthcare systems and research institutions intensify their focus on precision diagnostics and real-time visualization of biological processes. Growth is being driven by the increasing adoption of advanced imaging modalities such as molecular imaging, live-cell imaging, and multimodal imaging systems that enable detailed structural and functional analysis. Technological advancements in imaging sensors, contrast agents, and software integration are enhancing image resolution, speed, and analytical accuracy. Demand is further supported by the rising prevalence of chronic diseases and the growing need for early and accurate diagnosis. As regulatory bodies emphasize evidence-based clinical decision-making, bio-imaging technologies are becoming essential tools in both research and clinical environments.
Metabolomics Technology Market Size, Share & Trends Analysis Report by Products and Services (Metabolomics Instruments and Metabolomics Bioinformatics), by Application (Drug Discovery, Biomarkers, Toxicology, and Personalized Medicine) Forecast Period, (2026-2035)
Published: Apr 2026
Metabolomics technology market valued at $4,724.2 million in 2025 and is projected to reach $10,364.1 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global metabolomics technology market is gaining momentum as life science researchers and pharmaceutical companies increasingly rely on advanced analytical techniques to decode complex metabolic profiles. The growing emphasis on precision medicine, biomarker discovery, and systems biology is driving the demand for high-resolution technologies such as mass spectrometry and nuclear magnetic resonance. Additionally, the expansion of multi-omics research and the need for comprehensive metabolic insights are encouraging the adoption of integrated data analysis platforms. As regulatory and research environments shift toward evidence-based and data-intensive approaches, metabolomics technologies are becoming essential tools for accelerating discovery and improving clinical outcomes.
Biophotonics Market Size, Share & Trends Analysis Report by Technology (In-Vitro, In-Vivo), by Application (Medical Diagnostics, Therapeutics (e.g., laser-based treatments), Biosensing & Bioimaging, Drug Discovery & Development, Agriculture & Food Testing, Environmental Monitoring, Forensic Science, and Others), Forecast Period (2026–2035)
Published: May 2026
Biophotonics market was valued at $52.9 billion in 2025 and is projected to reach $107.2 billion by 2035, growing at a CAGR of 7.4% during the forecast period (2026-2035). Market growth is driven by the increasing adoption of optical imaging technologies in clinical diagnostics and life science research. Rising prevalence of chronic diseases has strengthened the demand for non-invasive and high-precision diagnostic solutions. Continuous advancements in laser-based therapies and spectroscopy techniques are enhancing treatment efficiency and expanding application areas. Growing investments in biomedical research and drug discovery activities are further supporting the uptake of biophotonics solutions. Expanding use of these technologies in environmental monitoring and food safety analysis is also contributing to steady market expansion.
CRISPR in Agriculture Market Size, Share & Trends Analysis Report by Target Type (Crops, Livestock, and Aquaculture), and by End-User (Academic & Research Institutes, Biotech & Agricultural R&D Companies, Crop & Livestock Breeding Companies, and Others), Forecast Period (2026-2035)
Published: Apr 2026
CRISPR in Agriculture market was valued at $1.54 billion in 2025 and is projected to reach $8.04 billion by 2035, growing at a CAGR of 18.0% during the forecast period (2026-2035). The global CRISPR in agriculture market is expanding as advances in gene-editing technologies enable precise modifications in crops, livestock, and aquaculture species, enhancing yield, disease resistance, and overall productivity. Increasing adoption by academic and research institutes, as well as biotechnology and agricultural R&D companies, is driving innovation and accelerating the development of commercially viable solutions. Regulatory frameworks in key regions are gradually evolving to support the safe application of CRISPR, which encourages investment and commercialization. Additionally, growing demand for sustainable agricultural practices and improved food security is motivating crop and livestock breeding companies to integrate gene-editing tools into conventional breeding programs.
Biological Safety Testing Market Size, Share & Trends Analysis Report by Product & Services (Kits & Reagents, Instruments, and Testing Services) by Test Type (Sterility Testing, Endotoxin Testing, Bioburden Testing, Cell Line Authentication & Characterization, Adventitious Agent Detection, Residual Host Contaminant Detection, and Others) and by End User (Pharmaceutical & Biotechnology Companies, CROs / CDMOs, Academic & Research Institutes, and Medical Device Companies) Forecast Period, (2026-2035)
Published: Apr 2026
Biological safety testing market valued at $6,203.5 million in 2025 and is projected to reach $16,411.1 million by 2035, growing at a CAGR of 10.3% during the forecast period (2026-2035). The global biological safety testing market is progressing steadily as biopharmaceutical companies, contract research organizations, and vaccine manufacturers intensify their focus on ensuring product safety, regulatory compliance, and quality assurance throughout the development lifecycle. Growth is being supported by the increasing complexity of biologics, including monoclonal antibodies, cell and gene therapies, and vaccines, which require rigorous contamination and safety validation. Rising adoption of advanced detection technologies such as rapid microbiological methods, PCR-based assays, and automated endotoxin testing systems is further strengthening testing efficiency. Demand is also being driven by stringent regulatory frameworks mandating comprehensive safety testing for biologics before commercialization. As the industry prioritizes risk mitigation and product integrity, biological safety testing solutions are becoming essential for maintaining compliance and accelerating approval timelines.
Blood Screening Market Size, Share & Trends Analysis Report by Product Type (Reagents & Kits, Instruments, and Software & Services) by Technology (Enzyme and Chemiluminescent immunoassays (EIA/CLIA), Nucleic Acid Amplification Testing (NAT), Chemiluminescence Immunoassay (CLIA), Western Blotting, and Next-Generation Sequencing (NGS)) and by End User (Blood Banks, and Hospitals & Diagnostic Laboratories) Forecast Period (2026-2035)
Published: Feb 2026
Blood screening market was valued at $3.7 billion in 2025 and is projected to reach $10.9 billion by 2035, growing at a CAGR of 11.3% during the forecast period (2026–2035). The growing need for safe transfusions globally has made efficient and high-volume blood screening solutions increasingly essential. Increasing volumes of donations combined with the varied transfusion needs from across the globe further underscore the central role that screening technologies play in ensuring a safe blood supply, in addition to avoiding the risk of transfusion-transmissible diseases.
Cerebrovascular Diseases Treatment Market Size, Share & Trends Analysis Report by Type of Stroke (Ischemic, and Hemorrhagic), by Treatment (Medication, and Surgical Procedure), by End User (Hospitals, Surgical Clinics, and Research Institutes) Forecast Period, (2026-2035)
Published: Mar 2026
Cerebrovascular diseases treatment market was valued at $5.8 billion in 2025 and is projected to reach $10.1 billion by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035).
Hemapheresis Market Size, Share & Trends Analysis Report by Technology (Centrifugation, Membrane Separation, Selective Adsorption) by Product (Hemapheresis Devices, and Hemapheresis Disposables) by Procedure (Photopheresis, Plasmapheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Others), and By Application (Hematology, Neurology, Renal Disease, and Others) Forecast Period (2025-2035)
Published: Feb 2026
Hemapheresis market was valued at $3.8 billion in 2024 and is projected to reach $8.4 billion by 2035, growing at a CAGR of 7.6% during the forecast period (2025-2035). The market growth is driven by factors like the increasing prevalence of chronic diseases, a rising demand for blood components and plasma-derived medicines, and advancements in technology. Key restraints include the high cost of devices and procedures, limited awareness, and regulatory complexities. The market is also experiencing growth due to a focus on personalized medicine, increased government initiatives, and expanding applications in treating autoimmune and neurological disorders.
Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics, and Genomics Studies, and Others), and by Ownership Type (Commercial, Academics/Research), Forecast Period 2025-2035
Published: Feb 2026
Biological sample handling market was valued at $15.2 billion in 2024 and is projected to grow at a CAGR of 7.8%, reaching $45.6 billion by 2035. The biological sample handling market is evolving, driven by the growing need for precise sample preservation to support future diagnostic accuracy. Advances in cold chain logistics and automation have significantly enhanced the integrity of samples during transport and storage. Companies such as Thermo Fisher Scientific have provided advanced cryopreservation methods to support the growing demand. Hamilton Company has solutions, including automated storage systems for various specimen types that make aspects of the management process automated and limit contamination risk along the way. As personalized medicine continues to grow, demand for reliable handling of tissue and blood (and other clinical samples) continues to expand. Research facilities are adopting highly scalable, high-throughput storage solutions.
Cancer Gene Therapy Market Size, Share & Trends Analysis by Therapy (Gene Transfer Immunotherapy, Oncolytic Virotherapy, and Gene Induced Immunotherapy), and by End-Users (Hospitals, Research Institutes, and Biotech Companies), Forecast Period (2026-2035)
Published: Mar 2026
Cancer gene therapy market was valued at $4.3 billion in 2025 and is projected to reach $9.8 billion by 2035, growing at a CAGR of 8.7% during the forecast Period (2026-2035). The market is growing rapidly due to factors like increasing cancer incidence, advancements in genetic engineering, and the rise of personalized medicine. Key drivers include the growing number of approved therapies like CAR-T, extensive research and development, and strategic collaborations to enhance manufacturing capacity.
Genomic Biomarker Market Size, Share & Trends Analysis Report by Type (Predictive Biomarkers, and Prognostic Biomarkers) by Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, and Others), and by End-User (Diagnostic and Research Laboratories, Hospitals, and Others) Forecast Period (2025-2035)
Published: Feb 2026
Genomic biomarker market was valued at $8.4 billion in 2024 and is projected to reach $41.7 billion by 2035, growing at a CAGR of 15.8% during the forecast period (2025–2035). Genomic biomarkers are DNA and RNA traits used as diagnostic indicators, disease characterization, and therapy selection tools. The body's response to treatment, as well as pathological and physiological processes, is represented by genomic biomarkers. Testing for genomic biomarkers can find molecular changes in a single gene, a group of genes, or a whole genome. A relationship between a genetic biomarker and the likelihood of developing a disease may or may not have strong supporting data. Functional laboratory evaluations and genetic epidemiology evidence are two variables that contribute to the clinical validity and usability of genomic biomarkers.
Biomarker Market Size, Share & Trends Analysis by Type (Genomic Biomarker, and Protein Biomarker) By Application (Drug Discovery & Development, Diagnostic, Prognostic, Predictive, and Others ) By Disease (Cancer, Cardiac, Renal, Central Nervous System Disease, and Others) By End-User (Hospitals, Diagnostic Centre, and Research Institute), Forecast Period (2026-2035)
Published: Mar 2026
Biomarker market was valued at $52 billion in 2025 and is projected to reach $141.7 billion by 2035, growing at a CAGR of 10.7% during the forecast Period (2026-2035). The market is driven by demand for personalized medicine, rising chronic diseases (cancer, neurodegenerative), tech advancements (AI, omics, liquid biopsies), and increased R&D investment. Key factors fueling this growth are better early disease detection, targeted therapies (companion diagnostics), and improved clinical decision-making.
Renal Biomarker Market Size, Share & Trends Analysis By Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, and Pharmacodynamic Biomarkers), by Diagnostic Technique (Elisa, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle, and Enhanced Turbidimetric Immunoassay), and by End-User (Hospitals, Diagnostic Labs, and Research Centres), Forecast Period (2026-2035)
Published: Mar 2026
Renal biomarker market was valued at $2.9 billion in 2025 and is projected to reach $5.2 billion by 2035, growing at a CAGR of 6.1% during the forecast Period (2026-2035). The market is driven by the rising prevalence of chronic and acute kidney diseases, an aging global population, and technological advancements like multiplex assays and AI-driven diagnostics. These factors are fueling demand for more accurate and early-stage detection methods, leading to growth in the market for both diagnostic tools and services.
3D Cell Culture Market Size, Share & Trends Analysis By Product (Scaffold-Based 3d Cell Culture, Scaffold-Free 3d Cell Culture and Other), By Application (Cancer and Stem Cell Research, Drug Discovery, Toxicology and Tissue Engineering & Regenerative Medicine), and By End user (Pharmaceutical & Biotechnology Companies, Research Institutes and Other), Forecast Period (2026-2035)
Published: Mar 2026
3D cell culture market was valued at $1.3 billion in 2025 and is projected to reach $3.9 billion by 2035, growing at a CAGR of 11.6% during the forecast period (2026-2035). The market is growing due to advancements in drug discovery, regenerative medicine, and personalized medicine, supported by the development of more accurate, in vivo-mimicking models. Its key factors driving this expansion include the increasing adoption of 3D cultures for cancer research and toxicology testing, a rising demand for alternatives to animal testing, and technological progress in areas like microfluidics and bioprinting.
3D Printed Drugs Market Size, Share & Trends Analysis by Dosage Forms (Tablet, Capsules, Multi-Drug Implant, Nanoparticles, Solutions, Nano suspension, Encapsulated within a polymer, and Implant), By Technology (Inkjet Printing, Zip-Dose, Fused Deposition Modelling (FDM), Stereolithography (SLA), and others) By Application (Dental, Hearing & Audibility Aid, Medical Implants, Neurology, and Orthopedic), Forecast Period (2026-2035)
Published: Mar 2026
3D printed drugs market was valued at $132.6 million in 2025 and is projected to reach $515.7 million by 2035, growing at a CAGR of 14.7% during the forecast period (2026-2035). The market growth is driven primarily by the demand for personalized medicine and advancements in additive manufacturing technology. Key factors contributing to this growth include the ability to create customized dosages and complex formulations, improve patient compliance through features like quick-dissolving pills, and enable on-demand, decentralized drug manufacturing.
Diagnostic Biomarker Market Size, Share & Trends Analysis By Application (Oncology, Cardiology, Neurology, Nephrology and Others), By Diagnostic Technique (Elisa, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, and Particle-Enhanced Turbidimetric Immunoassay and Others), and By End-User (Hospitals & Diagnostic Labs and Research Centers), Forecast Period (2026-2035)
Published: Mar 2026
Diagnostic biomarker market was valued at $5.1 billion in 2025 and is projected to reach $38.9 billion by 2035, growing at a CAGR of 22.7% during the forecast period (2026-2035). The market is growing due to the increasing prevalence of chronic diseases like cancer and cardiovascular disorders, the rising demand for personalized medicine, and significant advancements in technology like genomics and AI. Key factors driving this growth include increased investments in R&D, supportive regulatory frameworks, and the expansion of diagnostic applications for early and precise disease detection, especially through non-invasive methods like liquid biopsies.
HLA Typing for Transplant Market Size, Share & Trends Analysis Report By Type (Molecular Assays, and Non-Molecular Assays) By Product & Services (Reagents, Software, and Instruments) By Application (Diagnostics, and Research) By End-Users (Academic Institutes & Research Centers, Hospitals & Transplant Centers, and others) Forecast, 2026-2035
Published: Feb 2026
HLA typing for transplant market was valued at $1,211.3 million in 2025 and is projected to reach $2,196.80 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The global HLA Typing for transplant market is expanding steadily as the demand for precise donor-recipient matching continues to rise. Advancements in molecular diagnostics and sequencing technologies are enhancing the accuracy and speed of HLA typing, making transplantation procedures safer and more effective. The increasing prevalence of organ failures and the corresponding growth in transplant procedures are further driving the need for reliable HLA testing. Healthcare providers and diagnostic laboratories are investing in high-resolution typing solutions to reduce post-transplant complications and improve patient outcomes.
Metabolomics Biomarker Market Size, Share & Trends Analysis Report By Application (Biomarker Discovery, Drug Discovery and Assessment, Toxicology Testing, Functional Genomics, Nutrigenomics, And Personalized Medicine.), By Technology (Chromatography, Mass Spectrometry (MS), Nuclear Magnetic Resonance (NMR) Spectroscopy, and Bioinformatics Tools & Services), By Organization Size (Large Enterprises and Small & Medium-Sized Enterprises (SMES)), and By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROS), and Diagnostic Laboratories), Forecast Period (2025-2035)
Published: Feb 2026
Metabolomics biomarker market was valued at $415.8 million in 2024 and is projected to reach $1,651.6 million by 2035, growing at a CAGR of 13.4% during the forecast period (2025–2035). The metabolomics market has grown rapidly as a result of metabolomics, which combines techniques to identify and analyze cellular metabolites using advanced analytical methods with statistical and multivariate methods for data extraction and interpretation. Significant investments have been made in the development of analytical methods for different cellular products, such as gene expression (transcripts), proteins, and metabolites. This method has been applied to many different biological systems using GC-MS, including plants, microbial, urine, and plasma. Metabolomics uses additional studies such as LC-MS/MS, GC-MS, and/or NMR to identify and characterize as many metabolites as possible. It can additionally be used for metabolic fingerprints (or footprints of exogenous and/or secreted metabolites).
EPO Biomarkers Market Size, Share & Trends Analysis by Biomarker Type (Erythropoietin Alfa, Erythropoietin Beta, Erythropoietin Zeta, Erythropoietin Theta, Recombinant Human Erythropoietin, and Darbepoietin Alfa), By Applications (End-Stage Renal Disorder, Oncology, Rheumatoid Arthritis, Aids, Neurology, Hematology, and Others), and By End-User (Diagnostic Centers, Ambulatory Care and Surgical Centers, and Hospitals& Clinics), Forecast Period (2026-2035)
Published: Mar 2026
EPO biomarkers market was valued at $65 million in 2025 and is projected to reach $98.7 million by 2035, growing at a CAGR of 4.3% during the forecast Period (2026-2035). The global EPO (Erythropoietin) Biomarkers market is growing, driven by personalized medicine needs, advancements in diagnostics, and rising prevalence of anemia in CKD & cancer, though regulatory scrutiny of synthetic EPO (ESAs) impacts use, pushing focus to precise monitoring; North America leads due to R&D, Asia-Pacific shows fast growth, with key drivers being cancer, kidney disease, HIV/AIDS, & demand for companion diagnostics. In contrast, market growth relies on accurate testing & drug development.
Automated Pipetting System Market Size, Share & Trends Analysis Report by Application (Proteomics, Clinical Diagnostic, Drug Discovery, and Genomics), by Type (Stand-Alone System, Bench Top Workstation, and Multi-Channel System), by Instrument (Pipette Tips, Dispenser, Burette, Software, and Others), and by Industry (Biotechnology and Pharma Industries, Hospital and Diagnostic Laboratory, Academic Institute, and Research Institute) Forecast Period, (2026-2035)
Published: Apr 2026
Automated pipetting system market valued at $4,625.6 million in 2025 and is projected to reach $10,189.1 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global automated pipetting system market is advancing steadily as laboratories and research organizations intensify their focus on precision, reproducibility, and workflow efficiency in liquid handling processes. Growth is being driven by the increasing adoption of automation in genomics, proteomics, and clinical diagnostics, where high-throughput sample processing and accuracy are critical. The integration of robotic platforms with advanced software, AI-enabled workflow optimization, and cloud-based data management systems is streamlining laboratory operations and reducing manual errors. Demand is further supported by the rising volume of complex assays and the need for standardized protocols in research and diagnostic applications. As laboratories continue to prioritize scalability and data integrity, automated pipetting systems are becoming essential tools in modern life science environments.
Pharmaceutical Filtration Market By Application, By Products , By End Users - Global Industry Share, Growth, Competitive Analysis And Forecast, 2017-2022
Published: Feb 2026
The Global pharmaceutical filtration market is expected to grow at a
CAGR of 11.1 % during 2017-2022. Pharmaceutical filtration is the
process of removing unwanted particles such as solid impurities and
undissolved powders from the processed components leading to reduction
in bacteria. The filters inhibit the processed solution from
contamination which helps in maintaining sterility.
Colorectal Cancer Diagnosis and Therapeutics Market Size, Share & Trends Analysis by Type (Adenocarcinomas, Carcinoid Tumors, Lymphomas, Sarcomas, and Gastrointestinal Stromal Tumors (GISTS)), by Diagnosis (Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Others (Biopsy)), By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, and Immunotherapy), By End-User (Multispecialty Hospitals, and Cancer Research Centers), Forecast Period (2026-2035)
Published: Feb 2026
Colorectal cancer diagnosis and therapeutics market was valued at $13.6 billion in 2025 and is projected to reach $20.9 billion by 2035, growing at a CAGR of 4.5% during the forecast period (2026-2035). The global market is driven by the increasing incidence of the disease, fueled by lifestyle factors and an aging population. Key factors include advancements in diagnostic technologies, rising healthcare spending, growing government initiatives, and the development of targeted and personalized therapies. Regulatory approvals for new treatments and a greater focus on early detection through non-invasive screenings are also significant market drivers.
Non-Small Cell Lung Cancer Market Size, Share & Trends Analysis Report by Type (Adenocarcinomas, Squamous Cell Carcinoma, Large Cell Carcinomas, and Others) by Therapy (Chemotherapy, Targeted Therapy, Radiation Therapy, Surgery, Cryosurgery, and Others) by Diagnosis (CT Scan, X-Rays, Sputum Cytology, Bronchoscopy, Laboratory Tests, Thoracoscopy, and Others), and by End-User Industry (Multispeciality Hospitals, and Cancer Research Centers) Forecast Period (2025-2035)
Published: Feb 2026
Non-small cell lung cancer market was valued at $18.4 billion in 2024 and is projected to reach $35.8 billion by 2035, growing at a CAGR of 6.4% during the forecast period (2025–2035). The market growth is driven by factors like rising cancer prevalence due to smoking, air pollution, and an aging population. Key growth drivers include advances in diagnostics like CT scans and molecular testing, and the development of targeted therapies and immunotherapies for specific genetic mutations (e.g., EGFR, ALK). The market is also expanding due to increased demand for personalized treatment approaches and the overall growth of the oncology market.
Fetal Bovine Serum Market Size, Share & Trends Analysis by Product Type (Charcoal Stripped, Chromatographic, Dialyzed FBS, Stem Cell, and Others) By End-User (Bioproduct & Pharmaceutical Companies, Research Laboratories, Academic Institutes, and Others) By Application (Industrial Research and Research and Scientific Research), Forecast Period (2026-2035)
Published: Feb 2026
Fetal bovine serum market was valued at $2.1 billion in 2025 and is projected to reach $7.3 billion by 2035, growing at a CAGR of 13.3% during the forecast period (2026-2035). The market is driven by research in cell culture, biopharmaceuticals, and regenerative medicine, leading to significant growth, particularly in the production of vaccines, stem cell therapies, and other biologics. Key drivers include increased investment in drug discovery and personalized medicine, while restraints include supply chain constraints, the availability of alternatives, ethical concerns, and batch variability.
Cardiac Biomarker Market Size, Share & Trends Analysis Report by Type (Troponins (I and T), Creatine Kinase-MB (CK-MB), Myoglobin, and Natriuretic Peptides (BNP and NT-proBNP), and Ischemia-modified Albumin (IMA)) by Application (Acute Coronary Syndrome (ACS), Myocardial Infarction (Heart Attack), Congestive Heart Failure (CHF), and Others) and by End-User (Laboratory Testing, and Point-of-Care Testing) Forecast Period (2025-2035)
Published: Feb 2026
Cardiac biomarker market was valued at $4.8 billion in 2024 and is projected to reach $20.7 billion by 2035, growing at a CAGR of 14.3% during the forecast period (2025–2035). Cardiac biomarkers are enzymes, proteins, or hormones released in the bloodstream when the heart is damaged or stressed. A cardiac biomarker test is performed to diagnose acute coronary syndrome and cardiac ischemia by measuring the levels of cardiac biomarkers. The cardiac biomarkers include troponin (I and T), creatinine kinase (CK), CK-MB, and myoglobin. An increase in one or more of these biomarkers in the blood can identify potential heart damage in a patient. This allows for rapid and accurate diagnosis and suitable treatment for their condition. The increasing incidences of heart attacks increase the demand for testing cardiac biomarkers in patients suffering from chest pain and other symptoms.
Bone Cancer Diagnosis and Therapeutics Market Research By Type (Primary Bone Cancer and Secondary Bone Cancer), By Diagnosis (MRI Scans, X-Rays, CT-Scan, Radionuclide Bone Sensors, Biopsy, and Other), By Therapies (Radiation Therapy, Cryosurgery, and Other), and By End-User (Multispecialty Hospitals and Cancer Research Centers) Forecast Period, (2026-2035)
Published: May 2026
Bone cancer diagnosis and therapeutics market was valued at $3.20 billion in 2025 and is projected to reach $5.74 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The global bone cancer diagnosis and therapeutics market is advancing steadily, supported by continuous improvements in oncology care infrastructure and clinical research. Hospitals are adopting integrated diagnostic imaging and targeted treatment protocols to manage complex skeletal malignancies more effectively. Companies such as F. Hoffmann-La Roche Ltd. provide oncology therapies and diagnostic solutions that contribute to comprehensive cancer management. Increasing collaboration between research institutions and pharmaceutical manufacturers is accelerating the development of refined treatment approaches.
Global Cancer Biomarker Market Size, Share & Trends Analysis Report by Biomarker Type (Genetic Biomarker and Protein Biomarker), By Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, and Cervical Cancer), by Application (Drug Discovery & Development, Diagnosis, Risk Assessment, and Prognostics), and by Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, and Bioinformatics) Forecast Period (2025-2035)
Published: Feb 2026
The global cancer biomarker market is anticipated to grow at a significant CAGR of 12.4% during the forecast period. Biomarker testing is a method of looking for cancer-related genes, proteins, and other chemicals (also known as biomarkers or tumor markers). It comprises distinct patterns in each person's cancer. Some biomarkers have an impact on the effectiveness of cancer therapy. Thus, due to the increasing prevalence of cancer coupled with the rising awareness related to the usage of biomarkers at various stages of cancer is fuelling the market growth. According to the World Health Organization (WHO), in 2020, cancer is a leading cause of death globally, accounting for nearly 10 million deaths. Another factor that intends to drive the market is the usage of cancer biomarkers in drug discovery and technological development by the key market players.
Skin Cancer Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Cancer Type (Melanoma, and Non-Melanoma), by Diagnosis Type (Dermatoscopy, Biopsy, Imaging Techniques, Molecular Diagnostics, and Blood Tests), by Therapeutic Type (Surgical Procedures, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Photodynamic Therapy, Topical Treatments, and Others), and by End User (Hospitals, Specialty Dermatology Clinics, Cancer Treatment Centers, Ambulatory Surgical Centers, Diagnostic Laboratories, and Research & Academic Institutes) Forecast Period (2025-2035)
Published: Feb 2026
Skin cancer diagnosis and therapeutics market was valued at $14,258 million in 2024 and is projected to reach $25,160 million by 2035, growing at a CAGR of 5.3% from 2025 to 2035. The companies are utilizing AI and imaging technologies to improve early detection, reduce costs, and decrease dermatologist reliance, thereby driving market growth in underserved regions. For instance, in April 2025, British HealthTech company Skin Analytics secured $18.3 million in Series B funding from Intrepid Growth Partners to expand its AI skin cancer detection technology, DERM, to Europe, Australia, and the US market. The investment follows Skin Analytics' EU MDR Class III CE mark approval, making DERM the world's first legally authorized AI medical device to independently make clinical decisions on skin cancer without human review.
Media, Sera and Reagents Market Size, Share & Trends Analysis By Media (Classical Media and Salt, Serum-Free Media, Specialty Media, and Stem Cell Culture Media), By Sera (FBS (Fetal Bovine Serum), Adult Bovine Sera and Other Sera), By Reagents (Buffers and Salt Solution, Cytokines and Growth Factors, Cell Dissociation Reagents, Balanced Salt Solutions, Contamination Detection Kits and Other) and By End User (Pharmaceutical/Biotechnology Industry and Research Institutes), Forecast Period (2026-2035)
Published: Feb 2026
Media, sera and reagents market was valued at $3.7 billion in 2025 and is projected to reach $8.3 billion by 2035, growing at a CAGR of 8.5% during the forecast Period (2026-2035). The market is expanding rapidly due to factors like the rising prevalence of chronic diseases, increased R&D investment in biopharmaceuticals, and growing demand for personalized medicine. Technological advancements, such as automation and data analytics in bioprocessing, also significantly drive growth. Key drivers include the need for biologics, such as vaccines and antibodies, as well as opportunities presented by contract research and manufacturing.
Lab-on-a-Chip Market Size, Share & Trends Analysis Report by Product Type (Reagents & Consumables, and Instruments) by Application (Genomics, Proteomics, Diagnostics, and Drug Discovery) by Technology (DNA Microarrays, and Microfluidic Chip), and By End-User (Hospitals and Diagnostic Labs, Pharmaceutical Companies, and Individuals) Forecast Period (2025-2035)
Published: Feb 2026
Lab-on-a-Chip market was valued at $6.1 billion in 2024 and is projected to reach $16.3 billion by 2035, growing at a CAGR of 9.4% during the forecast period (2025–2035). The market is growing due to demand for faster diagnostics, personalized medicine, and advancements in drug discovery, while being driven by factors like rising chronic diseases and increasing R&D investment. Challenges include complex and costly micro-manufacturing processes, as well as the potential for clogging in microchannels.
Liquid Handling Systems Market Research and Forecast, 2017-2022
Published: Feb 2026
The global liquid handling systems market is anticipated to grow with
the CAGR of 8.2%during the period 2017-2022. The major factors that are
driving the growth of the liquid handling systems market are estimated
to be the assay miniaturization in drug discovery and inclusion of
automation in medical institutions and research centers.
Organ Preservation Market Research and Forecast 2017-2022
Published: Feb 2026
The global organ preservation market is expected to grow at a CAGR of
7.2% during the forecast period (2017-2022). Organ preservation is the
process by which organs are preserved outside of the body or organism to
reuse.
Needle Free Drug Delivery Devices Market Size, Share & Trends Analysis Report by Technology (Jet Injectors, Inhalation Systems, Transdermal Patch Systems, and Novel Needle-Free Technologies), By Application (Insulin Delivery, Vaccination, Pain Management, Pediatric Drug Delivery, and Other Therapeutic Applications), By End User (Hospitals & Clinics, Home Care Settings, and Ambulatory) Forecast Period, (2026-2035)
Published: Apr 2026
Needle free drug delivery devices market valued at $620.6 million in 2025 and is projected to reach $1,641.7 million by 2035, growing at a CAGR of 10.3% during the forecast period (2026-2035). The global Needle Free Drug Delivery Devices market is gaining momentum as healthcare systems increasingly prioritize safer, more efficient, and patient-friendly drug administration methods. Growth is being driven by the rising need to minimize needle-stick injuries, reduce cross-contamination risks, and improve patient compliance, particularly in chronic disease management. Advancements in jet injection technology, transdermal systems, and inhalation-based delivery methods are enabling precise dosing without the use of conventional needles. Demand is further supported by expanding vaccination programs and the growing preference for self-administration solutions in homecare settings. As healthcare providers emphasize safety, convenience, and cost-efficiency, needle-free delivery technologies are becoming a vital component of modern therapeutic practices.
Cryonics Technology Market Size, Share & Trends Analysis Report by Cryoprotective Agents (Permeating Cryoprotectants and Non-Permeating Cryoprotectants), by Method (Slow Freezing, Vitrification, and Ultra-Rapid), by Application (Animal Husbandry, Fishery Science, Medical Science, Preservation of Microbiology Culture, and Conserving Plant Biodiversity), and by End-User (Life Science and Healthcare Facilities, and Research Laboratories), Forecast Period (2026-2035)
Published: Apr 2026
Global cryonics technology market was valued at $815.2 million in 2025 and is projected to reach $1,785.5 million by 2035, growing at a CAGR of 8.2% from 2026 to 2035. The global market is experiencing sustained expansion, supported by increasing demand for advanced preservation techniques across biomedical and research applications. Continuous advancements in preservation formulations and protocols have improved the viability and stability of biological materials, encouraging broader adoption. The growing emphasis on regenerative medicine, cell-based research, and long-term biological storage further contributes to market progression. Additionally, rising investments in life sciences infrastructure and laboratory capabilities are strengthening product uptake. Expanding research activities in both developed and emerging economies are also creating consistent demand for high-quality preservation solutions. Collectively, these factors are contributing to steady and measurable market growth.
Bio Electronics Market Research and Forecast 2017-2022
Published: Feb 2026
The Bioelectronics Market is expected to grow at a modest CAGR of 12.1%
during 2017-2022. Bioelectronics contribute and evaluate the new
technologies to expand the biological sector that enable in raising the
efficiency of the medical community. Bioelectronics adopted various
number of ideas, methods and technology which are bio electromagnetics,
instrumentation, neural networks, robotics, and sensor technologies.
Biobanking Market Size, Share & Trends Analysis Report by Product (Equipment, Consumables, Services, And Software & Informatics) By Sample Type (Blood & Blood Products, Human Tissues, Cell Lines / Primary Cells / Pbmcs / Stem Cells, Nucleic Acids, Biological Fluids, And Microbiome) and by Application (Research & Academic Studies, Drug Discovery & Development, Diagnostics & Biomarker Development, Regenerative Medicine, Precision/Personalized Medicine And Epidemiology, Forensics, And Others) Forecast Period (2025-2035)
Published: Feb 2026
Biobanking market was valued at $8.3 billion in 2024 and is projected to reach $20.1 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2025–2035). The market drivers for biobanking include the expansion of precision and personalized medicine, necessitating extensive and diverse sample libraries for genomic research and targeted therapies. Growth in genomics and multi-omics research highlights the need for high-quality biological samples for large-scale studies. The expanding pipeline for cell and gene therapies calls for viable cell lines, particularly for complex diseases. Integrating advanced technology in biobanks enhances sample management and throughput. Increased government and private funding support the development of biobanking infrastructure. Additionally, a rising incidence of chronic diseases and an increase in clinical trials underline the demand for biospecimens for research and validation.
Biochips Market Size, Share & Trends Analysis Report, By Type (DNA Chips, Lab-on-a-Chip, Protein Chips, and Others), By Fabrication Technology (Microarrays and Microfluidics), By End-User (Hospitals and Diagnostic Centers, Academic and Research Institutes, and Biotechnology and Pharmaceutical Companies) Forecast Period (2025-2035)
Published: Feb 2026
Biochips market was valued at $14,303 million in 2024 and is projected to reach $48,365 million by 2035, growing at a CAGR of 11.8% from 2025 to 2035. The major factors that are augmenting the growth of the market include technological innovations and the rising demand for personalized medicine. The rising drug development pipeline and emerging demand for genomics research-oriented products are also some crucial factors accelerating market growth. However, certain factors are restraining the growth of the market, which include the high cost of biochips and stringent government regulations. Additionally, the COVID-19 pandemic has further accelerated market growth.
Micro Guide Catheters Market Research and Forecast 2017-2022
Published: Feb 2026
The Micro guide catheters market is expected to grow at a modest CAGR of
8% during 2017-2022. A catheter is a lean tube medical appliance which
can be inserted into the human body during the surgical trial.
Protein Engineering Market Size, Share & Trends Analysis by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Coagulation Factor, Vaccines, and Others), By Product (Instruments, Services and Software, and Reagents), and by End-User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Contract Research Organizations), Forecast Period (2026-2035)
Published: Feb 2026
Protein engineering market was valued at $3.5 billion in 2025 and is projected to reach $15.8 billion by 2035, growing at a CAGR of 16.4% during the forecast period (2026-2035). The market is driven by the increasing demand for personalized medicine, biopharmaceuticals, and advanced therapies for conditions like cancer and autoimmune diseases. Factors such as rising investments in synthetic biology, technological advancements (including AI/ML in protein design), and the growing need for novel enzymes in the agrochemical and biofuel industries are also fueling growth. Restraining factors include the high cost of equipment and development, though this is being mitigated by AI and automation.
Protein Labeling Market Size, Share & Trends Analysis By Product (Reagents & Kits, Labels / Tags & Probes, Kits, and Services), By Labeling Technique (In-Vitro Labeling, In-Vivo Labeling, Bioorthogonal Labeling, and Detection Modality), By Application (Immunological Techniques, Cell-Based Assays / Flow Cytometry / Live-Cell Imaging, Proteomics & Mass Spectrometry, Drug Discovery & ADME Studies / Biomarker Discovery, And Diagnostics & Clinical Assays), and By End User ( Pharmaceutical & Biotechnology companies, Academic & Research Institutes, Contract Research Organizations (CROs), Clinical & Diagnostic Laboratories / Hospitals, and Industrial), Forecast Period (2026-2035)
Published: Feb 2026
Protein labeling market was valued at $3.0 billion in 2025 and is projected to reach $7.9 billion by 2035, growing at a CAGR of 10.2% during the forecast period (2026-2035). The market growth is driven by increased R&D spending, technological advancements, and rising demand for diagnostics and personalized medicine. Key factors include the growth of proteomics research, bioengineering adoption, and innovation in labeling reagents and techniques, while market growth is also influenced by factors like a rising incidence of chronic diseases and growing healthcare expenditure.
CRISPR Market Size, Share & Trends Analysis Report by Application (Cell Line Engineering, CRISPR Plasmid, Gene Database/Gene Library, Genetic Engineering, Genetically Modified Organisms or Crops, Genome Editing, Human Stem Cells), and by End-User (Academic Institutes, Biotechnology Companies, Pharmaceuticals Companies, and Research and Development Institutes), Forecast Period (2025-2035)
Published: Feb 2026
CRISPR market size, valued at $2,650 million in 2024, is projected to grow to $8,890 million by 2035, registering a CAGR of 11.6% during 2025–2035. The CRISPR market growth is driven by increasing government and private funding, as well as rising demand for CRISPR, coupled with advancements in technology. CRISPR has wide applications in genome engineering, RNA editing, Gene drive, Gene function, in vitro genetic depletion, biomedicine, disease models, and many more.
Electrophoresis Market Size, Share & Trends Analysis Report by Product (Electrophoresis Reagents and Electrophoresis Systems), by Application (Diagnostic Applications and Research Applications), and by End-Use (Academic Institutions, Hospitals & Diagnostic Centres, and Others) Forecast Period (2025-2035)
Published: Feb 2026
The global electrophoresis market is anticipated to grow at a significant CAGR of 6.0% during the forecast period. The rising incidence of cancer, infectious diseases, and genetic disorders, as well as increased funding for genomic, proteomic, and electrophoresis research, the increasing number of industry-academic research collaborations, the growing use of capillary electrophoresis with mass spectroscopy, the increasing use of next-generation sequencing, and the increase in the number of clinical, forensic, and research laboratories, are all factors driving the electrophoresis market.
Membrane Separation Technology Market Research and Forecast 2017-2022
Published: Feb 2026
Membrane separation technology is defined as a process, which is used to
purify and separate components from the mixture. It is widely used in
the commercial and industrial processes.
Surgical Instrument Tracking System Market Research and Analysis 2017-2022
Published: Feb 2026
Surgical Instrument Tracking Systems Market is growing at a faster pace
owing to the increasing incidence of instrument misplacement and rising
prevalence of hospital-acquired infections are propelling this market
substantially.
Freeze-Drying Market Size, Share & Trends Analysis by Type (Vacuum Systems, Loading and Unloading, Controlling and Monitoring Systems, Manifolds, Clean in Place Systems, Drying Chambers, and Other Freeze-Drying Accessories), By Technology (Tray Style Freeze Dryers and Manifold Freeze Dryers) By Scale of Operation (Industrial Scale Freeze Dryers, Pilot Scale Freeze Dryers, and Lab Scale Freeze Dryers), Forecast Period (2026-2035)
Published: Mar 2026
freeze-drying market was valued at $2.4 billion in 2025 and is projected to reach $5.3 billion by 2035, growing at a CAGR of 8.3% from 2026 to 2035. The global market is expanding steadily, supported by sustained investment in advanced manufacturing technologies and infrastructure development across key regions. Increasing emphasis on product quality, regulatory compliance, and process optimization is encouraging organizations to upgrade their existing systems and adopt more efficient solutions. Growing demand from end-use industries, coupled with rising international trade activities, is further contributing to revenue growth. In addition, technological advancements and the integration of automation are enhancing operational reliability and scalability. Strategic collaborations, capacity expansions, and continuous innovation by industry participants are also strengthening market penetration. Collectively, these factors are creating a stable foundation for long-term market growth.
Stem Cells Market Size, Share & Trends Analysis By Cell Type (Adult, Human Embryonic Stem Cells (hESCs), Induced Pluripotent Stem Cells (iPSCs), and Others), By Application (Regenerative Medicine / Therapeutic Use, Emergen Research, Drug Discovery & Development, and Research), By Technology (Cell Acquisition, Cell Production, Cryopreservation, and Expansion & Sub?culture), By Therapy Type (Allogeneic, and Autologous) and By End User ( Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), Forecast Period (2026-2035)
Published: Feb 2026
Stem cells market was valued at $18.7 billion in 2025 and is projected to reach $53.5 billion by 2035, growing at a CAGR of 11.1% during the forecast period (2026-2035). The market is growing, driven by increased investment in R&D, the rising prevalence of chronic diseases, and advancements in regenerative medicine, which are fueling more clinical trials and personalized therapies. Key factors include the demand for new treatments for conditions like cancer and heart disease, the growth of precision medicine, and the increasing number of cell therapy production facilities.
Central Nervous System (CNS) Biomarker Market Size, Share & Trends Analysis Report by Application (Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others) by Type (Safety Biomarker, Efficacy Biomarker, Predictive Biomarker, Prognostic Biomarker, and Validation Biomarker) and by End User (Diagnostic Labs, Hospitals and Clinics, and Research Centers) Forecast Period (2025-2035)
Published: Feb 2026
Central nervous system (CNS) biomarker market was valued at $6.5 billion in 2024 and is projected to reach $16.1 billion by 2035, growing at a CAGR of 8.6% during the forecast period. The market is primarily driven by the rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, coupled with increasing demand for early diagnosis, disease monitoring, and personalized treatment approaches. Among applications, drug discovery & development hold the largest market share, while personalized medicine is witnessing the fastest growth. By type, predictive biomarkers are gaining significant traction, and research centers are emerging as key end users driving adoption. North America, led by the United States, dominates the market due to advanced healthcare infrastructure, strong R&D investments, and the presence of leading pharmaceutical and biotechnology companies. Continuous technological advancements and regulatory support are further fueling market expansion globally.
Antinuclear Antibody (ANA) Test Market Size, Share & Trends Analysis Report by Product Type (Assay Kits & Reagents, Antinuclear Antibody Test System, and Antinuclear Antibody Test Software), by Test Type (Indirect Immunofluorescence, Enzyme-Linked Immunosorbent Assay (ELISA), and Multiplex Testing), by Disease Type (Systemic Lupus Erythematosus, Sjogren’s Syndrome, Rheumatoid Arthritis, Scleroderma, and Others), and by End-User (Hospitals and Clinical Laboratories), Forecast Period (2026-2035)
Published: Feb 2026
Antinuclear antibody test market was valued at $2,117.10 million in 2025 and is projected to reach $4,262.32 million by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The global antinuclear antibody test market is advancing steadily, supported by rising autoimmune disease prevalence and continuous improvements in diagnostic accuracy. Laboratories and healthcare providers are placing greater emphasis on early detection and disease monitoring, encouraging wider adoption of ANA testing. Growing healthcare expenditure and improved access to diagnostic services in developing nations are further reinforcing demand. In parallel, investments in automation and advanced testing platforms are enhancing laboratory efficiency. Strategic collaborations among diagnostic firms and research institutions are fostering technological innovation.
Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR-Based Genome Editing, TALEN-Based Genome Editing, Zinc Finger Nucleases (ZFNs), and Other Technologies), by Application (Cell Line Engineering, Genetic Engineering (Plant and Animal), Gene Therapy, Drug Discovery and Development, and Other Applications), and by End Users (Biotechnology and Pharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Other End Users), Forecast Period (2026-2035)
Published: Apr 2026
Genome editing market was valued at $13.2 billion in 2025 and is projected to reach $50.7 billion by 2035, growing at a CAGR of 14.5% during the forecast period (2026-2035). The market is growing due to the rapid advancement and adoption of CRISPR-based genome editing technologies, which offer higher precision, efficiency, and scalability compared to earlier methods, thereby accelerating their use across research and therapeutic applications. In parallel, the increasing focus on gene therapy for the treatment of genetic disorders and chronic diseases is driving demand for reliable genome editing platforms, as these technologies enable targeted modification at the molecular level. This trend is further supported by rising investments from biotechnology and pharmaceutical companies aimed at expanding gene-based pipelines and strengthening innovation capabilities. Additionally, the growing use of genome editing in drug discovery and cell line engineering is enhancing research productivity and reducing development timelines.
Flow Cytometry Market Size, Share & Trends Analysis Report by Product Type (Instruments, Reagents & Consumables, Software), by Technology (Fluorescence-based Flow Cytometry, Mass Cytometry (CyTOF), and Spectral Flow Cytometry), by Application (Research Applications, Clinical Diagnostics, Drug Discovery & Development, and Others), Forecast Period, (2026-2035)
Published: May 2026
Flow cytometry market was valued at $10.2 billion in 2025 and is projected to reach $21.7 billion by 2035, growing at a CAGR of 7.9% during the forecast period (2026-2035). The global flow cytometry market is experiencing steady expansion driven by continuous advancements in life sciences research and biomedical technologies. Increasing adoption of high-throughput analytical techniques is enhancing the efficiency of cellular analysis across multiple domains. Growing emphasis on precision medicine and personalized healthcare is further supporting demand for advanced cytometry solutions. Expanding applications in clinical diagnostics and pharmaceutical research are contributing to broader market utilization. Technological improvements in instrumentation, reagents, and data analysis software are improving accuracy and operational capabilities. Overall, rising investment in research and development activities is sustaining long-term market growth momentum.
Leukemia Cancer Market Size, Share & Trends Analysis Report by Type (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia), by Diagnose and Monitor (Blood Test, Bone Marrow Test, Imaging Test, Lymph Node Biopsy, Lumbar Puncture, and Urine Test), and by Treatment (Chemotherapy, Radiation Therapy, Targeted Therapy, Biological Therapy, and Steam Cell Therapy), Forecast Period (2026-2035)
Published: Apr 2026
Global leukemia cancer market was valued at $23.6 billion in 2025 and is projected to reach $56.2 billion by 2035, growing at a CAGR of 9.1% from 2026 to 2035. The global leukemia market is experiencing growth driven by several key factors. The increasing prevalence of leukemia globally has heightened demand for effective diagnostic and therapeutic solutions. Advances in targeted therapies and personalized medicine have expanded treatment options, improving patient outcomes. Rising adoption of innovative diagnostic tools enables earlier and more accurate detection, supporting better disease management. Continuous research and development efforts by leading pharmaceutical and biotechnology companies are introducing new products to the market. Additionally, supportive regulatory frameworks and improved healthcare infrastructure in emerging regions are facilitating greater access to leukemia care.
Proteomics Market Size, Share & Trends Analysis Report by Product and Services (Instrumentation Technology, Reagents, and Software and Services), and by Application (Clinical Diagnostics, Drug Discovery and Development, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Proteomics market is anticipated to grow at a CAGR of 16.6% during the forecast period (2024-2031). The market is growing rapidly owing to technological advancements, increased R&D investments, and expanding biomedical research applications. Improvements in mass spectrometry, chromatography, and protein microarray technologies enhance the sensitivity, resolution, and throughput of proteomics analysis, while automation and robotics improve efficiency and reduce variability. Significant investments from governments, private sectors, and academic institutions drive research in biomarker discovery, drug development, and personalized medicine creating demand for the proteomics market.
Indian Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Female Infertility Diagnosis (Ovulation Testing, Hysterosalpingography, Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others), by Male Infertility Diagnosis (Semen Analysis, Genetic Testing, Testicular Biopsy, Hormone Testing, and Others), and by Infertility Treatment (Drugs and Medicine, Surgical Interventions, Assisted Reproductive Technology (ART), and Others) Forecast Period (2024-2031)
Published: Feb 2026
Indian infertility diagnosis and treatment market is anticipated to grow at a CAGR of 12.5% during the forecast period (2024-2031). India's rising infertility rates are influenced by factors such as delayed marriages, obesity, diabetes, and thyroid disorders. Lifestyle changes, technological advancements, and greater awareness of infertility treatments play a major role in promoting the Indian infertility diagnosis and treatment market. The modernization of healthcare facilities, partnerships with international fertility centers, and progress in genetic testing are improving access to advanced treatments, thereby boosting the market.
Rat Model Market Size, Share & Trends Analysis by Technology (Micro Injection, Embryonic Stem Cell Injection, Nuclear Transferase Technology, and CRISPR), By Type (Inbred Rats, Knockout Rats, Outbred Rats, and Others), Forecast Period (2026-2035)
Published: Feb 2026
Rat model market was valued at $1.5 billion in 2025 and is projected to reach $3.3 billion by 2035, growing at a CAGR of 7.6% during the forecast period (2026-2035). Rat models are widely utilized in biomedical research due to their similarities to humans, essential for understanding disease mechanisms and drug testing. Key drivers of their market include advancements in genetic engineering, particularly gene-editing tools like CRISPR/CAS9 that enable the creation of customized models reflecting human diseases. Additionally, the surge in R&D for pharmaceuticals, especially for chronic conditions, and the trend of outsourcing preclinical testing to Contract Research Organizations (CROs) are accelerating demand. Moreover, ongoing government and private funding for life sciences research supports market growth, particularly in North America and the Asia-Pacific.